Novel-alkynyl-substituted 3-phenylpyrrolidine-2,4-diones and use thereof as herbicides

ABSTRACT

The present invention relates to novel effective alkynyl-substituted 3-phenylpyrrolidine-2,4-diones according to the general formula (I) or agrochemically acceptable salts thereof, 
     
       
         
         
             
             
         
       
     
     where
 
X═C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl or C 3 -C 6 -cycloalkyl; Y═C 1 -C 4 -alkyl or C 3 -C 6 -cycloalkyl, n=1, 2 or 3; m=1 or 2; R 1 ═C 1 -C 6 -alkyl, or C 3 -C 6 -cycloalkyl, R 2 =hydrogen or methyl; R 3 ═C 1 -C 3 -alkoxy-C 1 -C 3 -alkyl, or a saturated five- or six-membered heterocycle with an oxygen or sulphur atom; G=hydrogen, a cleavable group L or a cation E.
 
     The invention also relates to the use of the compounds according to the invention for controlling weeds and weed grasses in crops of useful plants.

CROSS REFERENCE TO RELATED APPLICATIONS

This application is divisional application of U.S. patent application Ser. No. 15/738,292, filed Dec. 20, 2017, which is a § 371 National Stage Application of PCT/EP2016/064132, filed Jun. 20, 2016, which claims priority to European Application No. 15173092.6 filed Jun. 22, 2015. Each of these applications is incorporated by reference in its entirety.

BACKGROUND OF THE INVENTION Field of the Invention Description

The present invention relates to novel effective alkynyl-substituted 3-phenylpyrrolidine-2,4-diones according to the general formula (I) or agrochemically acceptable salts thereof, and to the use thereof for controlling weeds and weed grasses in crops of useful plants.

Description of Related Art

The compound class of 3-arylpyrrolidine-2,4-diones and their preparation and use as herbicides are well known from the prior art.

Moreover, however, for example bicyclic 3-arylpyrrolidine-2,4-dione derivatives (EP-A-355 599, EP-A-415 211 and JP-A 12-053 670 ff.) and substituted monocyclic 3-arylpyrrolidine-2,4-dione derivatives (EP-A-377 893 and EP-A-442 077 ff.) with a herbicidal, insecticidal or fungicidal effect are also described.

Alkynyl-substituted N-phenylpyrrolidine-2,4-diones with a herbicidal effect are also known from WO 96/82395, WO 98/05638, WO 01/74770, WO 14/032702 or WO15/040114.

The effectiveness of these herbicides against harmful plants is dependent on numerous parameters, for example on the application rate used, the preparation form (formulation), the harmful plants to be controlled in each case, the spectrum of harmful plants, the climate and soil proportions, as well as the action time and/or the rate of degradation of the herbicide. In order to develop a sufficient herbicidal effect, numerous herbicides from the group of 3-arylpyrrolidine-2,4-diones require high application rates and/or narrow spectra of harmful plants, which makes their application economically unattractive. There is therefore the need for alternative herbicides which have improved properties and are economically attractive and simultaneously efficient.

SUMMARY

Consequently, the object of the present invention is to provide novel compounds which do not have the stated disadvantages.

The present invention therefore relates to novel alkynyl-substituted N-phenylpyrrolidine-2,4-diones of the general formula (I),

or an agrochemically acceptable salt thereof, where

-   X═C₁-C₄-alkyl, C₁-C₄-haloalkyl or C₃-C₆-cycloalkyl, -   Y═C₁-C₄-alkyl or C₃-C₆-cycloalkyl, -   n=1, 2 or 3, -   m=1 or 2, -   R¹═C₁-C₆-alkyl, or C₃-C₆-cycloalkyl, -   R²=hydrogen or methyl, -   R³═C₁-C₃-alkoxy-C₁-C₃-alkyl, or a saturated five- or six-membered     heterocycle with an oxygen or sulphur atom, -   G=hydrogen, a cleavable group L or a cation E; where     -   L=one of the following radicals

-   -   in which         -   R⁴═C₁-C₄-alkyl or C₁-C₃-alkoxy-C₁-C₄-alkyl,         -   R⁵═C₁-C₄-alkyl,         -   R⁶═C₁-C₄-alkyl, an unsubstituted phenyl or a phenyl             substituted one or more times with halogen, C₁-C₄-alkyl,             C₁-C₄-haloalkyl, C₁-C₄-alkoxy, C₁-C₄-haloalkoxy, nitro or             cyano,         -   R⁷, R^(7′)=in each case independently of one another methoxy             or ethoxy,         -   R⁸ and R⁹=in each case independently of one another methyl,             ethyl, phenyl or together form a saturated 5-, 6- or             7-membered ring, or together form a saturated 5-, 6- or             7-membered heterocycle with an oxygen or sulphur atom,     -   E=an alkali metal ion, an ion equivalent of an alkaline earth         metal, an ion equivalent of aluminium or an ion equivalent of a         transition metal, a magnesium halogen cation, or         -   an ammonium ion, in which optionally one, two, three or all             four hydrogen atoms by identical or different radicals from             the groups hydrogen, C₁-C₅-alkyl, C₁-C₅-alkoxy or             C₃-C₇-cycloalkyl, which can in each case be substituted one             or more times with fluorine, chlorine, bromine, cyano,             hydroxy or be interrupted by one or more oxygen or sulphur             atoms, or         -   a cyclic secondary or tertiary aliphatic or heteroaliphatic             amino ion, for example morpholinium, thiomorpholinium,             piperidinium, pyrrolidinium, or in each case protonated             1,4-Diazabicyclo[2.2.2]octane (DABCO) or             1,5-diazabicyclo[4.3.0]undec-7-ene (DBU), or         -   a heterocyclic ammonium cation, for example in each case             protonated pyridine, 2-methylpyridine, 3-methylpyridine,             4-methylpyridine, 2,4-dimethylpyridine,             2,5-di-methylpyridine, 2,6-dimethylpyridine,             5-ethyl-2-methylpyridine, pyrrole, imidazole, quinoline,             quinoxaline, 1,2-dimethylimidazole, 1,3-dimethylimidazolium             methyl sulphate, or furthermore is a sulphonium ion.

DETAILED DESCRIPTION OF A PREFERRED EMBODIMENT

A general definition of the compounds of the invention is provided by the formula (I). Preferred substituents or ranges of the radicals given in the formulae mentioned above and below are illustrated hereinafter:

In the formula (I) and all the formulae which follow, alkyl radicals having more than two carbon atoms may be straight-chain or branched. Alkyl radicals are e.g. methyl, ethyl, n- or isopropyl, n-, iso, t- or 2-butyl, pentyls such as n-pentyl, 2,2-dimethylpropyl and 3-methylbutyl. Cycloalkyl is a carbocyclic saturated ring system having three to six carbon atoms, for example cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl.

Halogen is fluorine, chlorine, bromine or iodine.

The compounds of the formula (I) can, depending on the type of substituents, be present as geometric and/or optical isomers or isomer mixtures, in differing composition which can optionally be separated in the usual manner. Both the pure isomers and also the tautomer, isomer or enantiomer mixtures, their preparation and use, as well as compositions comprising these are provided by the present invention. However, for the sake of simplicity, the terminology used hereinbelow is compounds of the formula (I) although both the pure compounds and also optionally mixtures with different proportions of isomeric and tautomeric compounds are intended.

Reference is given to compounds in which

-   X═C₁-C₄-alkyl or C₃-C₆-cycloalkyl, -   Y═C₁-C₄-alkyl or C₃-C₆-cycloalkyl, -   n=1, 2 or 3, -   m=1 or 2, -   R¹=methyl, ethyl, isopropyl or cyclopropyl, -   R²=hydrogen or methyl, -   R³═C₁-C₃-alkoxy-C₁-C₃-alkyl, -   G=hydrogen, a cleavable group L or a cation E in which     -   L=one of the following radicals

-   -   in which         -   R⁴═C₁-C₄-alkyl,         -   R⁵═C₁-C₄-alkyl,         -   R⁶═C₁-C₄-alkyl, an unsubstituted phenyl or a phenyl             substituted with halogen, C₁-C₄-alkyl or C₁-C₄-alkoxy,         -   R⁷, R^(7′)=independently of one another methoxy or ethoxy,     -   E=an alkali metal ion, an ion equivalent of an alkaline earth         metal, an ion equivalent of aluminium or an ion equivalent of a         transition metal, or         -   an ammonium ion in which optionally one, two, three or all             four hydrogen atoms by identical or different radicals from             the groups hydrogen or C₁-C₅-alkyl, or a tertiary aliphatic             or heteroaliphatic ammonium ion, or a heterocyclic ammonium             cation, for example in each case protonated pyridine,             quinoline, quinoxaline, 1,2-dimethylimidazole,             1,3-dimethylimidazolium methyl sulphate, or also is a             sulphonium ion.

Particular preference is given to compounds of the general formula (I) in which

-   X=methyl, ethyl or cyclopropyl, -   Y=methyl or ethyl, -   n=1 or 2, -   m=1 or 2, -   R¹=methyl, ethyl, isopropyl or cyclopropyl, -   R²=hydrogen -   R³═CH₃CH₂OCH₂— or CH₃OCH₂—, -   G=hydrogen, a cleavable group L or a cation E in which -   L=one of the following radicals

-   -   in which         -   R⁴═C₁-C₄-alkyl,         -   R⁵═C₁-C₄-alkyl,     -   E=an alkali metal ion, an ion equivalent of an alkaline earth         metal, an ion equivalent of aluminium, an ion equivalent of a         transition metal or is a magnesium halogen cation, a         tetra-C₁-C₅-alkyl ammonium cation or a heterocyclic ammonium         cation, for example in each case protonated pyridine or         quinoline, or also is a sulphonium ion.

Very particular preference is given to compounds of the formula (I) in which

-   X=methyl or ethyl, -   Y=methyl or ethyl, -   n=1 or 2, -   m=1 or 2, -   R¹=methyl, ethyl, isopropyl or cyclopropyl, -   R²=hydrogen, -   R³═CH₃CH₂OCH₂— or CH₃OCH₂—, -   G=hydrogen, a cleavable group L or a cation E in which -   L=one of the following radicals

-   -   in which         -   R⁴=methyl, ethyl or isopropyl,         -   R⁵=methyl or ethyl,     -   E=a sodium, potassium, trimethylammoniumm, pyridinium,         quinolinium or trimethylsulphonium cation or an ion equivalent         of calcium or magnesium.

The preparation of the compounds according to the invention of the general formula (I) is known in principle and/or can take place in accordance with processes known in the literature, for example by

a) cyclizing a compound of the general formula (II)

in which X, Y, R¹, R² and R³, and n and m have the meanings given above, and R¹⁰ is alkyl, preferably methyl or ethyl, optionally in the presence of a suitable solvent or diluent, with a suitable base with formal cleaving off of the group R¹⁰OH, or b) reacting a compound of the general formula Ia

in which X, Y, R¹, R² and R³, and n and m have the meanings given above, with a compound of the general formula (III),

Hal-L  (III)

in which L has the meaning given above and Hal is a halogen, preferably chlorine or bromine or can be a sulphonic acid group, optionally in the presence of a suitable solvent or diluent, and also a suitable base. (c) by reacting compounds of the general formula (IV),

in which X, Y, R² and R³, m, n and G have the meanings given above, and U is a suitable leaving group, with a suitable alkynyl reagent of the general formula (V),

in which R³ has the meaning given above and W is hydrogen or a suitable leaving group, optionally in the presence of a suitable catalyst and a suitable base. Suitable leaving groups W are, for example, halogen atoms such as chlorine, bromine or iodine, alkylsulphonic ester groups such as, for example, triflate, mesylate or nonaflate, magnesium chloride, zinc chloride, a trialkyltin radical, and boric acid radicals such as B(OH)₂ or —B(Oalkyl)₂. Pd⁰ complexes in particular are very readily suitable as catalysts, where in many cases also the addition of Cu^((I)) salts may be very advantageous.

The described methodology is known in the literature in the prior art and moreover in this connection also under the keyword “palladium-catalysed cross-coupling”, “Sonogashira-, Negishi-, Suzuki-, Stille- or Kumada coupling”.

Alternatively, a compound of the general formula (IV) can also be reacted with an alkynyl reagent of the general formula (VI) in an analogous application of the coupling methodology described above, then cleaved into ethynyl compounds of the general formula (VIII) and these are finally converted with a suitable alkylating reagent to the compound (I) according to the invention, where in each case X, Y, R², R³, n, m, G and W have the described meaning and the cleavable group R¹¹ can be for example a group (C₁-C₄-alkyl)₂C—OH.

This technology, likewise known in the literature, is explained in more detail for example in Beilstein Journal of Organic Chemistry 2011, 7(55), 426-431 and Catalysis Communications 2015, 60, 82-87.

A further alternative consists in reacting a compound of the general formula (IV) with an alkynyl reagent of the general formula (IX) in an analogous application of the above-described coupling methodology. Then, the group R¹² can be cleaved off under suitable conditions, giving compounds according to the invention of the formula (I) where R³=Me, where in each case X, Y, R², n, m, G and W have the described meaning. R¹² is a C₁-C₄-trialkylsilyl radical.

This technology, known in the literature, is described for example in the Journal of Medicinal Chemistry 2007, 50 (7), 1627-1634.

The required precursors of the general formula (II)

can be prepared via known processes by reacting an amino acid ester of the general formula (VI) with a phenyl acetic acid of the general formula (VII), in which X, Y, R¹, R² and R³ and R¹⁰, and also n and m have the above-described meaning, optionally by adding a water-withdrawing agent and optionally in the presence of a suitable solvent or diluent.

A further variant for preparing compounds with the general formula (II) consists, for example, also in reacting a compound with the general formula (IIa), in which X, Y, R², R³, R¹⁰, R¹¹, n and m and U have the meaning given above, by the cross-coupling methodology already described.

Phenyl acetic acids of the general formula (VII)—namely 2,6-dimethyl-4-propargylphenyl acetic acid—are mentioned in principle in WO 2015/040114, but no access route to these compounds is described.

However, they can be prepared in accordance with processes known in the literature, for example by reacting a compound with the general formula (X), where X, Y, U, W, R³, R¹⁰ and R¹¹ are as defined above and R═C₁-C₄-alkyl, again with technology already described above with reagents of the general formula (V) or (V).

The compounds according to the invention of the formula (I) (and/or salts thereof), referred to hereinbelow together as “compounds according to the invention”, have an excellent herbicidal effectiveness against a broad spectrum of economically important mono- and dikotyledonous annual weeds. The active ingredients also act efficiently on perennial weeds which produce shoots from rhizomes, root stocks and other perennial organs and which are difficult to control.

The present invention therefore also provides a method for controlling unwanted plants or for regulating the growth of plants, preferably in plant crops, in which one or more compound(s) according to the invention is/are applied to the plants (for example harmful plants such as monocotyledonous or dicotyledonous weeds or unwanted crop plants), the seed (for example grains, seeds or vegetative propagules such as tubers or shoot parts with buds) or the area on which the plants grow (for example the area under cultivation). The compounds of the invention can be deployed, for example, prior to sowing (if appropriate also by incorporation into the soil), prior to emergence or after emergence. Specifically, mention may be made, by way of example, to a number of mono- and dikotyledonous weed flora which can be controlled by the compounds according to the invention, without any intention of limitation to certain varieties by virtue of the naming.

Monocotyledonous harmful plants of the genera: Aegilops, Agropyron, Agrostis, Alopecurus, Apera, Avena, Brachiaria, Bromus, Cenchrus, Commelina, Cynodon, Cyperus, Dactyloctenium, Digitaria, Echinochloa, Eleocharis, Eleusine, Eragrostis, Eriochloa, Festuca, Fimbristylis, Heteranthera, Imperata, Ischaemum, Leptochloa, Lolium, Monochoria, Panicum, Paspalum, Phalaris, Phleum, Poa, Rottboellia, Sagittaria, Scirpus, Setaria, Sorghum.

Dicotyledonous weeds of the genera: Abutilon, Amaranthus, Ambrosia, Anoda, Anthemis, Aphanes, Artemisia, Atriplex, Bellis, Bidens, Capsella, Carduus, Cassia, Centaurea, Chenopodium, Cirsium, Convolvulus, Datura, Desmodium, Emex, Erysimum, Euphorbia, Galeopsis, Galinsoga, Galium, Hibiscus, Ipomoea, Kochia, Lamium, Lepidium, Lindernia, Matricaria, Mentha, Mercurialis, Mullugo, Myosotis, Papaver, Pharbitis, Plantago, Polygonum, Portulaca, Ranunculus, Raphanus, Rorippa, Rotala, Rumex, Salsola, Senecio, Sesbania, Sida, Sinapis, Solanum, Sonchus, Sphenoclea, Stellaria, Taraxacum, Thlaspi, Trifolium, Urtica, Veronica, Viola, Xanthium.

If the compounds of the invention are applied to the soil surface before germination, either the emergence of the weed seedlings is prevented completely or the weeds grow until they have reached the cotyledon stage, but then they stop growing and ultimately die completely after three to four weeks have passed.

If the active ingredients are applied post-emergence to the green parts of the plants, growth stops after the treatment, and the harmful plants remain at the growth stage at the time of application, or they die completely after a certain time, such that competition by the weeds, which is harmful to the crop plants, is thus eliminated very early and in a lasting manner.

Although the compounds according to the invention have an excellent herbicidal activity towards mono- and dikotyledonous weeds, crop plants of economically important crops e.g. dicotyledonous crops of the genera Arachis, Beta, Brassica, Cucumis, Cucurbita, Helianthus, Daucus, Glycine, Gossypium, Ipomoea, Lactuca, Linum, Lycopersicon, Nicotiana, Phaseolus, Pisum, Solanum, Vicia, or monocotyledonous crops of the genera Allium, Ananas, Asparagus, Avena, Hordeum, Oryza, Panicum, Saccharum, Secale, Sorghum, Triticale, Triticum, Zea, in particular Zea and Triticum, are damaged only insignificantly, or not at all, depending on the structure of the particular compound according to the invention and its application rate. For these reasons, the present compounds are very suitable for selective control of unwanted plant growth in plant crops such as agriculturally useful plants or ornamental plants.

In addition, the compounds according to the invention (depending on their particular structure and the application rate deployed) have outstanding growth-regulating properties in crop plants. They intervene in the plants' own metabolism with regulatory effect, and can thus be used for controlled influencing of plant constituents and to facilitate harvesting, for example by triggering desiccation and stunted growth. Furthermore, they are also suitable for the general control and inhibition of unwanted vegetative growth without killing the plants in the process. An inhibition of the vegetative growth plays a large role in many mono- and dikotyledonous crops since, for example, the storage formation can be reduced or completely prevented as a result.

By virtue of their herbicidal and plant growth regulatory properties, the active ingredients can also be used to control harmful plants in crops of genetically modified plants or plants modified by conventional mutagenesis. In general, transgenic plants are characterized by particular advantageous properties, for example by resistances to certain pesticides, in particular certain herbicides, resistances to plant diseases or pathogens of plant diseases, such as certain insects or microorganisms such as fungi, bacteria or viruses. Other particular properties relate, for example, to the harvested material with regard to quantity, quality, storability, composition and specific constituents. For instance, there are known transgenic plants with an elevated starch content or altered starch quality, or those with a different fatty acid composition in the harvested material.

As regards transgenic crops, preference is given to the application of the compounds according to the invention in economically important transgenic crops of useful plants and ornamental plants, e.g. of cereals such as wheat, barley, rye, oats, millet, rice, maniok and corn or else crops of sugar cane, cotton, soybean, rapeseed, potatos, tomatoes, peas and other vegetable varieties. Preferably, the compounds of the invention can be used as herbicides in crops of useful plants which are resistant, or have been made resistant by genetic engineering, to the phytotoxic effects of the herbicides.

Conventional ways of producing novel plants which have modified properties in comparison to existing plants consist, for example, in traditional cultivation methods and the generation of mutants. Alternatively, novel plants with modified properties can be generated with the aid of recombinant methods (see, for example, EP-A-0221044, EP-A-0131624). For example, there have been descriptions in several cases of:

-   -   genetic modifications of crop plants for the purpose of         modifying the starch synthesized in the plants (e.g. WO         92/11376, WO 92/14827, WO 91/19806),     -   transgenic crop plants which are resistant to certain herbicides         of the glufosinate type (cf. e.g. EP A-0242236, EP-A-242246) or         glyphosate type (WO 92/00377) or the sulphonylurea type         (EP-A-0257993, USA 5013659),     -   transgenic crop plants, for example cotton, with the ability to         produce Bacillus thuringiensis toxins (Bt toxins), which make         the plants resistant to particular pests (EP-A-0142924,         EP-A-0193259),     -   transgenic crop plants with a modified fatty acid composition         (WO 91/13972),     -   genetically modified crop plants with novel constituents or         secondary metabolites, for example novel phytoalexins, which         bring about an increased disease resistance (EPA 309862,         EPA0464461),     -   genetically modified plants having reduced photorespiration,         which have higher yields and higher stress tolerance (EPA         0305398),     -   transgenic crop plants which produce pharmaceutically or         diagnostically important proteins (“molecular pharming”),     -   transgenic crop plants which feature higher yields or better         quality,     -   transgenic crop plants which are characterized by a combination         e.g. of the aforementioned new properties (“gene stacking”).

Numerous molecular biology techniques which can be used to produce novel transgenic plants with modified properties are known in principle; see, for example, I. Potrykus and G. Spangenberg (eds.) Gene Transfer to Plants, Springer Lab Manual (1995), Springer Verlag Berlin, Heidelberg, or Christou, “Trends in Plant Science” 1 (1996) 423-431).

For such recombinant manipulations, nucleic acid molecules which allow mutagenesis or sequence alteration by recombination of DNA sequences can be introduced into plasmids. With the aid of standard methods, it is possible, for example, to undertake base exchanges, remove parts of sequences or add natural or synthetic sequences. To join the DNA fragments with one another, adapters or linkers can be placed onto the fragments, see e.g. Sambrook et al., 1989, Molecular Cloning, A Laboratory Manual, 2nd edition Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., or Winnacker “Gene and Klone [Genes and clones]”, VCH Weinheim 2nd edition 1996.

For example, the generation of plant cells with a reduced activity of a gene product can be achieved by expressing at least one corresponding antisense RNA, a sense RNA for achieving a cosuppression effect, or by expressing at least one suitably constructed ribozyme which specifically cleaves transcripts of the abovementioned gene product. To this end, it is firstly possible to use DNA molecules which encompass the entire coding sequence of a gene product inclusive of any flanking sequences which may be present, and also DNA molecules which only encompass portions of the coding sequence, in which case it is necessary for these portions to be long enough to have an antisense effect in the cells. It is also possible to use DNA sequences which have a high degree of homology to the coding sequences of a gene product, but are not completely identical to them.

When expressing nucleic acid molecules in plants, the protein synthesized may be localized in any desired compartment of the plant cell. However, to achieve localization in a particular compartment, it is possible, for example, to join the coding region to DNA sequences which ensure localization in a particular compartment. Such sequences are known to those skilled in the art (see, for example, Braun et al., EMBO J. 11 (1992), 3219-3227; Wolter et al., Proc. Natl. Acad. Sci. USA 85 (1988), 846-850; Sonnewald et al., Plant J. 1 (1991), 95-106). The nucleic acid molecules can also be expressed in the organelles of the plant cells.

The transgenic plant cells can be regenerated by known techniques to give rise to entire plants. In principle, the transgenic plants may be plants of any desired plant species, i.e. not only monocotyledonous but also dicotyledonous plants.

Thus, transgenic plants can be obtained whose properties are altered by overexpression, suppression or inhibition of homologous (=natural) genes or gene sequences or expression of heterologous (=foreign) genes or gene sequences.

The compounds of the invention can be used with preference in transgenic crops which are resistant to growth regulators, for example dicamba, or to herbicides which inhibit essential plant enzymes, for example acetolactate synthases (ALS), EPSP synthases, glutamine synthases (GS) or hydroxyphenylpyruvate dioxygenases (HPPD), or to herbicides from the group of the sulphonylureas, the glyphosates, glufosinates or benzoylisoxazoles and analogous active ingredients.

When the active ingredients of the invention are used in transgenic crops, not only do the effects toward harmful plants which are observed in other crops occur, but often also effects which are specific to application in the particular transgenic crop, for example an altered or specifically widened spectrum of weeds which can be controlled, altered application rates which can be used for the application, preferably good combinability with the herbicides to which the transgenic crop is resistant, and influencing of growth and yield of the transgenic crop plants.

The invention therefore also provides for the use of the compounds of the invention as herbicides for control of harmful plants in transgenic crop plants.

In a preferred embodiment of the present invention, the compounds of the general formula (I) can also be used to control those harmful plants e.g. from the group Agrostis, Alopecurus, Apera, Avena, Brachiaria, Bromus, Cenchrus, Digitaria, Echinochloa, Eleusine, Eriochloa, Leptochloa, Lolium, Ottochloa, Panicum, Pennisetum, Phalaris, Poa, Rottboellia, Setaria and/or Sorghum weeds; in particular Alopecurus, Apera, Avena, Brachiaria, Bromus, Digitaria, Echinochloa, Eriochloa, Lolium, Panicum, Phalaris, Poa, Setaria and/or Sorghum weeds,

-   -   which are resistant to one or more herbicides inhibiting the         enzyme acetyl-CoA-carboxylase (ACCase). ACCase-inhibiting         herbicides are, inter alia, pinoxaden, clodinafop-propargyl,         fenoxaprop-P-ethyl, diclofop-methyl, fluazifop-P-butyl,         haloxyfop-P-methyl, quizalofop-P-ethyl, propaquizafop,         cyhalofop-butyl, clethodim, sethoxydim, cycloxydim, tralkoxydim         or butroxydim;     -   and/or are resistant to glyphosate,     -   and/or are resistant to one or more herbicides inhibiting the         acetolactate synthase (ALS), such as, for example, one or more         sulphonylurea herbicides (e.g. iodosulphurone-methyl,         mesosulphurone-methyl, tribenuron-methyl, triasulphurone,         prosulphurone, sulphosulphurone, pyrazosulphurone-ethyl,         bensulphurone-methyl, nicosulphurone, flazasulphurone,         iofensulphurone, metsulphurone-methyl, or any other         sulphonylurea disclosed in the “The Pesticide Manual”, 15th         edition (2009) or 16th edition (2012), C. D. S. Tomlin, British         Crop Protection Council, and/or one or more triazolopyrimidine         herbicides (e.g. florasulam, pyroxsulam or penoxsulam) and/or         one or more pyrimidinyl (thio or oxy) benzoate herbicides (e.g.         bispyribac-sodium or pyriftalid) and/or one or more         sulphonylamino-carbonyltriazolinone herbicides (e.g.         thiencarbazone-methyl, propoxycarbazone-sodium or         flucarbazone-sodium) and/or imidazolinone herbicides (e.g.         imazamox).

Specific examples of such harmful grasses resistant to ACCase and/or ALS inhibitors and/or glyphosate are, inter alia, Alopecurus myosuroides, Apera spica-venti, Avena fatua, Avena sterilis, Brachiaria decumbens, Brachiaria plantaginea, Digitatia horizontalis, Digitaria insularis, Digitaria sanguinalis, Echinochloa colona, Echinochloa crus-galli, Eleusine indica, Lolium multiflorum, Lolium rigidum, Lolium perenne, Phalaris minor, Phalaris paradoxa, Setaria viridis, Setaria faberi or Setaria glauca.

In a particularly preferred embodiment of the present invention, the compounds according to the invention of the general formula (I) can be used against harmful plants

-   -   which are resistant to one or more ACCase inhibiting herbicides         (e.g. selected from the above list) or are indeed at least         partially on account of mutations (e.g. substitution) of one or         more amino acids in the ACCase target site of the harmful plant         (cf. e.g. S. B. Powles and Qin Yu, “Evolution in Action: Plants         Resistant to Herbicides”, Annu. Rev. Plant Biol., 2010, 61, p.         317-347); and/or     -   which are resistant to glyphosate, and indeed at least partly on         account of mutation (e.g. substitution) of one or more amino         acids at the EPSPS target site in the weed in question to which         glyphosate is directed; and/or     -   which are resistant to one or more ALS-inhibiting herbicides         (e.g. selected from the above list of ALS-inhibiting herbicides)         and indeed at least partly on account of mutations (e.g.         substitution) of one or more amino acids in the ALS target site         in the weed in question (cf. e.g. S. B. Powles and Qin Yu,         “Evolution in Action: Plants Resistant to Herbicides”, Annu.         Rev. Plant Biol., 2010, 61, p. 317-347); and/or     -   which are resistant to one or more ACCase inhibiting herbicides         (e.g. selected from the above list) and/or to glyphosate and/or         to one or more ALS-inhibiting herbicides (e.g. selected from the         above list) and indeed at least partially through a         metabolically induced herbicide resistance, e.g. at least         partially due to a cytochrome P450-mediated metabolism (cf.         e.g. S. B. Powles and Qin Yu, “Evolution in Action: Plants         Resistant to Herbicides”, Annu. Rev. Plant Biol., 2010, 61, p.         317-347).

The compounds according to the invention exhibit superior properties compared to the compounds from the prior art, for example WO 2015/040114, compound 42.03 (see also the comparison data in Tables 9 and 10).

The compounds of the invention can be applied in the form of wettable powders, emulsifiable concentrates, sprayable solutions, dusting products or granules in the customary formulations. The invention therefore also provides herbicidal and plant-growth-regulating compositions which comprise the compounds of the invention.

The compounds according to the invention can be formulated in various ways according to which biological and/or chemical physical parameters are pregiven. Possible formulations include, for example: Wettable powders (WP), water-soluble powders (SP), water-soluble concentrates, emulsifiable concentrates (EC), emulsions (EW), such as oil-in-water and water-in-oil emulsions, sprayable solutions, suspension concentrates (SC), dispersions based on oil or water, oil-miscible solutions, capsule suspensions (CS), dusting products (DP), dressings, granules for scattering and soil application, granules (GR) in the form of micro granules, spray granules, absorption and adsorption granules, water-dispersible granules (WG), water-soluble granules (SG), ULV formulations, microcapsules and waxes. These individual formulation types are known in principle and are described, for example, in: Winnacker Küchler, “Chemische Technologie [Chemical Technology]”, Volume 7, C. Hanser Verlag Munich, 4th Ed. 1986, Wade van Valkenburg, “Pesticide Formulations”, Marcel Dekker, N.Y., 1973, K. Martens, “Spray Drying” Handbook, 3rd Ed. 1979, G. Goodwin Ltd. London.

The formulation auxiliaries required, such as inert materials, surfactants, solvents and further additives, are likewise known and are described, for example, in: Watkins, “Handbook of Insecticide Dust Diluents and Carriers”, 2nd ed., Darland Books, Caldwell N.J.; H. v. Olphen, “Introduction to Clay Colloid Chemistry”, 2nd ed., J. Wiley & Sons, N.Y.; C. Marsden, “Solvents Guide”, 2nd ed., Interscience, N.Y. 1963; McCutcheon's “Detergents and Emulsifiers Annual”, MC Publ. Corp., Ridgewood N.J., Sisley and Wood, “Encyclopedia of Surface Active Agents”, Chem. Publ. Co. Inc., N.Y. 1964, Schönfeldt, “Grenzflächenaktive Äthylenoxidaddukte [Interface-active ethylene oxide adducts]”, Wiss. Verlagsgesell., Stuttgart 1976, Winnacker Küchler, “Chemische Technologie [Chemical Technology]”, Volume 7, C. Hanser Verlag Munich, 4th Ed. 1986.

On the basis of these formulations, it is also possible to produce combinations with other pesticidally active substances, for example insecticides, acaricides, herbicides, fungicides, and also with safeners, fertilizers and/or growth regulators, for example in the form of a finished formulation or as a tankmix. Suitable safeners are e.g. mefenpyr-diethyl, cyprosulphamide, isoxadifen-ethyl, cloquintocet-mexyl and dichlormid.

Wettable powders are preparations uniformly dispersible in water which, alongside the active ingredient apart from a diluent or inert substance, also comprise surfactants of an ionic and/or non-ionic type (wetting agent, dispersant), e.g. polyoxyethylated alkylphenols, polyoxethylated fatty alcohols, polyoxethylated fatty amines, fatty alcohol polyglycolethersulphates, alkanesulphonates, alkylbenzenesulphonates, sodium ligninosulphonate, sodium 2,2′-dinaphthylmethane-6,6′-disulphonate, sodium dibutylnaphthalenesulphonate or else sodium oleoylmethyltaurate. To produce the wettable powders, the herbicidally active ingredients are finely ground, for example in customary apparatus such as hammer mills, blower mills and air-jet mills, and simultaneously or subsequently mixed with the formulation auxiliaries.

Emulsifiable concentrates are produced by dissolving the active ingredient in an organic solvent, for example butanol, cyclohexanone, dimethylformamide, xylene, or else relatively high-boiling aromatics or hydrocarbons or mixtures of the organic solvents, with addition of one or more ionic and/or nonionic surfactants (emulsifiers). Examples of emulsifiers which may be used are: Calcium alkylarylsulphonic acid salts such as Ca dodecylbenzenesulphonate or non-ionic emulsifiers such as fatty acid polyglycol esters, alkylaryl polyglycol ethers, fatty alcohol polyglycol ethers, propylene oxide ethylene oxide condensation products, alkylpolyethers, sorbitan esters such as e.g. sorbitan fatty acid esters or polyoxyethylene sorbitan esters such as e.g. polyoxyethylene sorbitan fatty acid esters.

Dustable powders are obtained by grinding the active ingredient with finely distributed solid substances, for example talc, natural clays such as kaolin, bentonite and pyrophyllite, or diatomaceous earth.

Suspension concentrates can be based on water or oil. They can be produced, for example, by wet grinding by means of standard commercial bead mills and optionally the addition of surfactants, as have already been listed e.g. above for the other types of formulation.

Emulsions, e.g. oil-in-water emulsions (EW), can be prepared, for example, by means of stirrers, colloid mills and/or static mixers using aqueous organic solvents and optionally surfactants, as have already been listed e.g. above for the other formulation types.

Granules can be prepared either by spraying the active ingredient onto adsorptive granular inert material or by applying active ingredient concentrates to the surface of carriers, such as sand, kaolinites or granular inert material, by means of adhesives, for example polyvinyl alcohol, sodium polyacrylate or else mineral oils. Suitable active ingredients can also be granulated in the manner customary for producing fertilizer granules—if desired in a mixture with fertilizers.

Water-dispersible granules are usually produced by the customary processes such as spray-drying, fluidized-bed granulation, pan granulation, mixing with high-speed mixers and extrusion without solid inert material.

For the production of pan, fluidized-bed, extruder and spray granules, see e.g. processes in “Spray Drying Handbook” 3rd Ed. 1979, G. Goodwin Ltd., London, J. E. Browning, “Agglomeration”, Chemical and Engineering 1967, pages 147 ff, “Perry's Chemical Engineer's Handbook”, 5th Ed., McGraw Hill, New York 1973, p. 857.

For further details regarding the formulation of crop protection compositions, see, for example, G. C. Klingman, “Weed Control as a Science”, John Wiley and Sons, Inc., New York, 1961, pages 81-96 and J. D. Freyer, S. A. Evans, “Weed Control Handbook”, 5th Ed., Blackwell Scientific Publications, Oxford, 1968, pages 101-103.

The agrochemical preparations generally comprise 0.1 to 99% by weight, in particular 0.1 to 95% by weight, of compounds according to the invention.

In wettable powders, the active ingredient concentration is e.g. about 10 to 90% by weight, the remainder to 100% by weight consists of customary formulation constituents. In the case of emulsifiable concentrations, the active ingredient concentration can be about 1 to 90, preferably 5 to 80% by weight. Dust-type formulations contain

1 to 30% by weight of active ingredient, preferably at most 5 to 20% by weight of active ingredient, sprayable solutions comprise about 0.05 to 80, preferably 2 to 50% by weight of active ingredient. In the case of water-dispersible granules, the active ingredient content depends partially on whether the active compound is present in liquid or solid form and on which granulation auxiliaries, fillers, etc., are used. In the water-dispersible granules, the content of active ingredient is, for example, between 1 and 95% by weight, preferably between 10 and 80% by weight.

In addition, the specified active ingredient formulations optionally comprise the adhesives, wetting agents, dispersants, emulsifiers, penetration agents, preservatives, frost protection agents and solvents, fillers, carriers and dyes, antifoams, evaporation inhibitors and agents influencing the pH and viscosity customary in each case.

On the basis of these formulations, it is also possible to produce combinations with other pesticidally active substances, for example insecticides, acaricides, herbicides, fungicides, and also with safeners, fertilizers and/or growth regulators, for example in the form of a finished formulation or as a tankmix.

For application, the formulations in commercial form are, if appropriate, diluted in a customary manner, for example in the case of wettable powders, emulsifiable concentrates, dispersions and water-dispersible granules with water. Dust-type preparations, granules for soil application or granules for scattering and sprayable solutions are not normally diluted further with other inert substances prior to application.

The required application rate of the compounds of the formula (I) varies with the external conditions, including temperature, humidity and the type of herbicide used. It can vary within wide limits, for example between 0.001 and 1.0 kg/ha or more of active substance, but it is preferably between 0.005 and 750 g/ha.

The examples below illustrate the invention by way of example.

A. Chemical Examples Example I-1

1.14 g (2.67 mmol) of the precursor were added dropwise in a solution of 10 ml of DMF to a solution of 8 ml of DMF and 748 mg (2.5 eq) of potassium t-butylate over the course of 30 min at room temperature and stirred at this temperature for 18 h. Then, the mixture was heated for 4 h at 40° C., the solvent was removed under reduced pressure and the residue was taken up in 100 ml of water. The mixture was adjusted to pH=1 with 1n hydrochloric acid and the resulting residue was filtered off, giving 1.00 g (95%) of the target compound A1 as colourless oil.

¹H-NMR (400 MHz, d6-DMSO): 3.33 (s, 1H, CH₂—OCH₃), 2.04 (s, 3H, CH₃—C≡C) Analogously to Example I-1 and also according to the general details relating to the production, the following compounds according to the invention were obtained.

TABLE 1 Ex. No. n m R³ X Y R¹ Note I-1 2 2 —CH₂CH₂OCH₃ Et Et Me nd I-2 2 2 —CH₂CH₂OCH₃ Me Et Me nd I-3 2 2 —CH₂CH₂OCH₃ Me Me Me nd I-4 2 2 —CH₂CH₂OCH₃ Me Me Cyclopropyl nd I-5 2 2 —CH₂OCH₃ Me Et Me nd I-6 2 2 —CH₂OCH₃ Et Et Me nd I-7 2 2 —CH₂OCH₃ Me Et Cyclopropyl nd I-8 2 2 —CH₂OCH₃ Me Me Cyclopropyl nd I-9 1 2 —CH₂OCH₃ Me Et Me cis I-10 1 2 —CH₂OCH₃ Me Et Me trans I-11 1 2 —CH₂OCH₃ Me Et Cyclopropyl trans I-12 1 2 —CH₂OCH₃ Me Et Cyclopropyl cis I-13 1 2 —CH₂OCH₃ Me Me Cyclopropyl trans I-14 1 2 —CH₂OCH₃ Me Me Cyclopropyl cis/trans mixture nd = not determined

Example Ia-1

1.00 g (2.6 mmol) of the compound (I-11) according to the invention was introduced with 0.5 ml of triethylamine and 1.5 mg of DMAP in 8 ml of dichloromethane and stirred for 10 min at 40° C. Then 0.315 g (2.9 mmol) of ethyl chloroformate in 2 ml of dichloromethane was slowly added dropwise and the mixture was then stirred for 6 h at 40° C. and then overnight at RT. 10 ml of sodium hydrogencarbonate solution were added and the organic phase was separated off. The residue remaining after concentration was purified by column chromatography (silica gel, gradient EtOAc/n-heptane), giving 0.920 g (77%) of the compound B1 according to the invention as isomer mixture. This gave, by column chromatography over silica gel (ethyl acetate/hexane v/v=20:80), in total 0.43 g (47%) of the transisomer in the form of colourless crystals with m.p. 183-184° C.

Analogously to Example Ia-1 and according to the general details relating to the production, the following compounds of the formula (I-1-b) are obtained:

TABLE 2 Ex. No. n m R³ X Y R¹ L Note Ia-1 1 2 —CH₂OCH₃ Me Et Cyclopropyl —COOEt trans Ia-2 1 2 —CH₂OCH₃ Me Me Cyclopropyl —COOEt nd Ia-3 2 2 —CH₂OCH₃ Me Et Me —COCH(CH₃)₂ trans Ia-4 2 2 —CH₂CH₂OCH₃— Me Et Me —COCH(CH₃)₂ nd Ia-5 2 2 —CH₂CH₂OCH₃— Et Et Me —COCH(CH₃)₂ nd Ia-6 1 2 —CH₂OCH₃ Me Et Me —COCH(CH₃)₂ trans Ia-7 1 2 —CH₂OCH₃ Me Et Me —COCH(CH₃)₂ cis Ia-8 1 2 —CH₂OCH₃ Me Et Me —COCH(CH₃)₂ trans Ia-9 1 2 —CH₂OCH₃ Me Et Me —COCH(CH₃)₂ cis Ia-10 1 2 —CH₂OCH₃ Me Et Cyclopropyl —COCH(CH₃)₂ cis/trans mixture Ia-11 1 2 —CH₂OCH₃ Me Et Cyclopropyl —COCH(CH₃)₂ trans Ia-12 1 2 —CH₂OCH₃ Me Et Cyclopropyl —COCH(CH₃)₂ cis Ia-13 2 2 —OCH₂CH₂OCH₃ Et Et Me —COCH(CH₃)₂ nd Ia-14 2 2 —OCH₂CH₂OCH₃ Me Et Me —COOEt nd Ia-15 1 2 —OCH₂CH₂OCH₃ Et Me Me —COOEt nd Ia-16 1 2 —CH₂OCH₃ Me Et Me —SO₂Me nd Ia-17 2 2 —CH₂OCH₃ Me Et Me —COOEt m.p. 197° C.

B. Preparation Examples (Starting Materials) Example II-1

1.10 g (4.5 mmol) of 4-cyclopropylethinyl-2-ethyl-6-methylphenyl acetic acid were dissolved in 20 ml of dichloromethane and admixed with one drop of DMF. 0.75 g (1.3 eq) of oxalyl chloride were added and the mixture was heated under reflux to boiling until gas stopped evolving. Then, the reaction solution was concentrated, admixed twice more with in each case 20 ml of dichloromethane and concentrated again in order finally to take up the residue in 4 ml of dichloromethane (solution 1). 1.015 (4.5 mmol) of 3-methoxymethylcyclopentane amino acid methyl ester-hydrochloride and 1 g of triethylamine were dissolved in 20 ml of dichloromethane and solution 1 was added dropwise over the course of 90 min. After stirring for 18 h, the mixture was admixed with 50 ml of water, and the organic phase was separated off, concentrated and purified by column chromatography (silica gel gradient EtOAc/n-heptane). This gave 1.16 g (62%) of the desired target compound.

Analogously to Example II-1 and according to the general details relating to the production, the following compounds of the formula (II) are obtained:

TABLE 3 Ex. No. n m R³ X Y R¹ Physical data II-2 2 1 —CH₂CH₂OMe Me Et Me ¹H-NMR (400 MHz, CDCl₃): 3.70 (s, 3H, OCH₃), 3.44 (pseudo t, 2H, CH₂—OCH₃), 2.05 (s, 3H, CH₃—C≡C) II-3 2 1 —CH₂OMe Me Et Me ¹H-NMR (400 MHz, CDCl₃): 3.70 (s, 3H, OCH₃), 3.07 (d, 2H, CH₂—OCH₃), 2.05 (s, 3H, CH₃—C≡C) II-4 2 1 —CH₂CH₂OMe Et Et Me ¹H-NMR (400 MHz, CDCl₃): 3.67 (s, 3H, OCH₃), 3.34 (pseudo t, 2H, CH₂—OCH₃), 2.07 (s, 3H, CH₃—C≡C)

Example (VII-1)

8.41 g (32.7 mmol) of literature-known methyl 4-bromo-2,6 dimethylphenyl acetate were initially introduced with 0.1 mol % of dichlorobistriphenylpalladium dichloride in a mixture of 45 ml of triethylamine and 18 ml of pyridine and 4.11 g (1.9 eq) of cyclopropylacetylene were added. The mixture was heated under reflux to boiling for 7.5 h and then stirred overnight at room temperature. The resulting salts were filtered off and in each case washed twice with triethylamine and diethyl ether. The mother liquor was concentrated under reduced pressure, and admixed firstly with water and then with 32 ml of a 3% strength hydrochloric acid solution. Then, extraction was carried out with ethyl acetate and this organic phase was washed twice with water. After drying the organic phase, concentration was performed and the resulting residue was purified by column chromatography (silica gel, gradient n-heptane/ethyl acetate). This thus gave 6.83 g (86%) of the desired compound.

¹H-NMR (400 MHz, CDCl₃): 7.07 (s, 2H, Ar—H), 3.67 (s, 5H, OCH₃ and CH₂—Ar), 2.26 (s, 3H, Ar—CH₃), 1.42 (s, 1H, CH-c-Pr)

Example (VII-2)

7.5 g (24.8 mmol) of methyl 2,6-diethyl-4-trimethylsilylpropynylphenyl acetate were dissolved in 200 ml of ethanol and admixed with a solution of 4 eq of potassium hydroxide in 200 ml of ethanol. The mixture was heated under reflux to boiling for 7 h, the solvent was removed and 500 ml of water were added. Then, hydrochloric acid was used to establish a pH of 1 and the mixture was extracted three times with 100 ml of ethyl acetate in each case. The combined organic phases were dried with sodium sulphate, concentrated and purified by column chromatography (silica gel, gradient EtOAc/n-heptane). This thus gave 4.3 g of compound (VII-2) according to the invention.

¹H-NMR (400 MHz, CDCl₃): 7.09 and 7.07 each s, 1H, Ar—H), 3.70 (s, 2H, CH₂—Ar), 2.62 (q, 2H, Ar—CH₂), 2.29 (s, 3H, Ar—CH₃), 2.03 (s, 3H, CH₃—C≡C), 1.18 (t, 3H, CH₃ —CH₂—Ar)

The following compounds are obtained analogously

TABLE 4 Ex. No. R X Y R³ Physical data VII-3 Me Et Et —CH₂SiMe₃ ¹H-NMR (300 MHz, CDCl₃): 7.07 (s, 2H, Ar—H), 3.70 (s, 2H, CH₂—Ar), 3.64 (s, 3H, OCH₃), 2.59 (q, 2H, CH₂—Ar), 0.16 (s, 9H, Si(CH₃)₃) VII-4 Me Me Et —CH₂SiMe₃ ¹H-NMR (400 MHz, CDCl₃): 3.68 (s, 2H, CH₂—Ar), 3.66 (s, 3H, OCH₃), 2.62 (q, 2H, CH₂—Ar), 0.16 (s, 9H, Si(CH₃)₃) VII-5 Me Me Me —CH₂SiMe₃ Oil VII-6 Me Me Et Me ¹H-NMR (300 MHz, CDCl₃): 3.66 (s, 2H, CH₂—Ar), 3.64 (s, 3H, OCH₃), 2.01 (s, 3H, CH₃—C≡C) VII-7 Me Et Et Me Oil VII-8 Me Me Me Me ¹H-NMR (400 MHz, CDCl₃): 3.68(s, 3H, OCH₃), 3.67 (s, 2H, CH₂—Ar), 2.03 (s, 3H, CH₃—C≡C) VII-9 Me Me Cl Me ¹H-NMR (400 MHz, CDCl₃): 3.81(s, 2H, CH₂—Ar), 3.67 (s, 3H, OCH₃), 2.03 (s, 3H, CH₃—C≡C) VII-10 Me Me Et —CH₂—C—(OH)(CH₃)₂ ¹H-NMR (400 MHz, CDCl₃): 3.78(s, 2H, CH₂—Ar), 3.75 (s, 3H, OCH₃), 1.63 (s, 6H, (CH₃)₂) VII-11 Me Me Cl —CH₂—C—(OH)(CH₃)₂ ¹H-NMR (400 MHz, CDCl₃): 3.85(s, 2H, CH₂—Ar), 3.68 (s, 3H, OCH₃), 1.60 (s, 6H, (CH₃)₂) VII-12 Me Me Me —CH₂—C—(OH)(CH₃)₂ ¹H-NMR (400 MHz, CDCl₃): 3.67 (s, 5H, OCH₃ and CH₂—Ar), 1.60 (s, 6H, (CH₃)₂) VII-13 H Et Et Me ¹H-NMR (400 MHz, CDCl₃): 7.12 (s, 2H, Ar—H), 3.72 (s, 2H CH₂—Ar), 2.62 (q, 2H, CH₂—Ar), 2.03 (s, 3H, Ar—C≡O—CH₃) VII-14 H Me Me Me ¹H-NMR (400 MHz, CDCl₃): 7.05 (s, 2H, Ar—H), 3.70 (s, 2H, CH₂—Ar), 3.66 (s, 3H, OCH₃), 2.01 (s, 3H, Ar—C≡O—CH₃), VII-15 H Me Et Cyclopropyl ¹H-NMR (400 MHz, d₆-DMSO): 7.03 (s, 2H, Ar—H), 3.60 (s, 2H, CH₂—Ar), 1.51 (s, 1H, CH-c-Pr) VII-16 H Me Me Cyclopropyl ¹H-NMR (400 MHz, d₆-DMSO): 7.03 (s, 2H, Ar—H), 3.57 (s, 2H, CH₂—Ar), 1.51 (s, 1H, CH-c-Pr) NMR data of selected examples NMR peak list method

The ¹H NMR data of selected examples are stated in the form of ¹H NMR peak lists. For each signal peak, first the δ value in ppm and then the signal intensity in round brackets are listed. The pairs of δ value-signal intensity numbers for different signal peaks are listed with separation from one another by semicolons.

The peak list for one example therefore has the form of:

δ₁ (intensity₁); δ₂ (intensity₂); . . . ; δ_(i) (intensity_(i)); . . . ; δ_(n) (intensity_(n))

The intensity of sharp signals correlates with the height of the signals in a printed example of an NMR spectrum in cm and shows the true ratios of the signal intensities. In the case of broad signals, several peaks or the middle of the signal and the relative intensity thereof may be shown in comparison to the most intense signal in the spectrum.

To calibrate the chemical shift of ¹H-NMR spectra, we used tetramethylsilane and/or the chemical shift of the solvent, particularly in the case of spectra measured in DMSO. Therefore, the tetramethylsilane peak may but need not occur in NMR peak lists.

The lists of the ¹H NMR peaks are similar to the conventional ¹H-NMR printouts and thus usually contain all peaks listed in a conventional NMR interpretation.

In addition, like conventional ¹H NMR printouts, they may show solvent signals, signals of stereoisomers of the target compounds which likewise form part of the subject-matter of the invention, and/or peaks of impurities.

When stating compound signals in the delta range of solvents and/or water, in our lists of 1H NMR peaks, the usual solvent peaks, for example peaks of DMSO in DMSO-D₆ and the peak of water are shown, which usually have on average a high intensity.

The peaks of stereoisomers of the target compounds and/or peaks of impurities usually have a lower intensity on average than the peaks of the target compounds (for example with a purity of >90%).

Such stereoisomers and/or impurities may be typical of the particular preparation process. Their peaks can thus help in this case to identify reproduction of our preparation process with reference to “by-product fingerprints”.

An expert calculating the peaks of the target compounds by known methods (MestreC, ACD simulation, but also with empirically evaluated expected values) can, if required, isolate the peaks of the target compounds, optionally using additional intensity filters. This isolation would be similar to the relevant peak picking in customary 1H-NMR interpretation.

Further details of ¹H NMR peak lists can be found in the Research Disclosure Database Number 564025.

Example Ia-7: ¹H-NMR( MHz, CDCl₃): δ = 7.261(50.0); 7.101(5.5); 7.084(5.2); 6.877(1.5); 6.851(1.5); 3.644(1.0); 3.456(1.0); 3.447(1.8); 3.438(1.1); 3.434(1.7); 3.425(3.2); 3.416(1.9); 3.406(25.1); 3.403(24.7); 3.375(2.7); 3.366(2.6); 3.352(1.8); 3.348(2.8); 3.343(1.7); 3.338(2.3); 3.324(0.4); 3.146(1.8); 2.981(1.5); 2.573(0.3); 2.565(0.3); 2.554(1.0); 2.548(1.6); 2.535(1.8); 2.530(3.7); 2.517(2.9); 2.513(4.8); 2.496(4.6); 2.478(2.9); 2.471(2.1); 2.465(2.3); 2.452(2.0); 2.446(2.1); 2.434(1.2); 2.428(1.2); 2.415(0.6); 2.409(0.6); 2.371(1.3); 2.344(1.0); 2.337(1.5); 2.314(1.3); 2.310(1.1); 2.287(1.0); 2.280(1.4); 2.253(1.0); 2.210(0.4); 2.199(2.1); 2.190(26.5); 2.178(1.5); 2.053(0.7); 2.046(0.8); 2.034(38.2); 2.017(1.0); 2.011(1.5); 2.004(2.0); 1.987(2.9); 1.969(1.2); 1.962(1.3); 1.953(0.5); 1.935(0.5); 1.887(0.4); 1.860(1.6); 1.843(3.0); 1.833(1.4); 1.825(2.1); 1.780(0.3); 1.705(1.3); 1.701(1.3); 1.696(1.4); 1.692(1.3); 1.667(1.2); 1.662(1.2); 1.658(1.2); 1.571(4.1); 1.256(0.9); 1.193(0.8); 1.185(0.3); 1.174(1.5); 1.155(9.0); 1.148(1.1); 1.136(17.5); 1.129(1.6); 1.118(8.0); 1.110(0.7); 1.014(1.2); 1.012(1.2); 0.996(12.7); 0.992(12.1); 0.984(1.7); 0.978(11.7); 0.975(11.7); 0.967(13.4); 0.966(15.7); 0.950(12.3); 0.948(14.3); 0.008(0.9); 0.000(32.2); −0.009(0.9) Example I-1: ¹H-NMR( MHz, CDCl₃): δ = 7.758(0.9); 7.350(0.6); 7.265(50.0); 7.146(15.1); 7.127(0.4); 7.070(0.3); 6.407(1.1); 4.727(1.0); 3.444(2.5); 3.428(6.1); 3.413(3.5); 3.395(1.5); 3.379(0.7); 3.323(0.9); 3.310(36.6); 3.287(6.8); 2.879(7.4); 2.785(6.2); 2.516(0.6); 2.496(1.1); 2.478(1.8); 2.460(4.1); 2.445(4.4); 2.442(4.4); 2.436(1.6); 2.427(4.3); 2.417(1.3); 2.409(2.0); 2.399(0.6); 2.391(0.9); 2.381(0.4); 2.372(0.4); 2.269(0.3); 2.217(0.4); 2.212(0.4); 2.063(0.7); 2.049(28.3); 2.039(1.9); 2.023(0.7); 1.999(0.7); 1.985(1.3); 1.975(1.3); 1.951(1.9); 1.941(2.2); 1.918(1.1); 1.908(1.7); 1.883(1.7); 1.855(1.8); 1.699(1.3); 1.646(0.4); 1.630(0.6); 1.615(0.5); 1.580(2.3); 1.543(4.0); 1.527(4.1); 1.512(2.0); 1.479(0.7); 1.199(0.4); 1.182(0.6); 1.170(0.7); 1.164(0.8); 1.134(2.0); 1.131(1.9); 1.116(2.4); 1.113(2.3); 1.103(15.7); 1.092(2.1); 1.084(32.7); 1.065(14.5); 0.008(0.6); 0.000(28.3); −0.008(0.9) Example Ia-13: ¹H-NMR( MHz, CDCl₃): δ = 7.264(22.2); 7.141(18.0); 5.298(18.0); 4.031(3.7); 4.013(12.5); 3.995(12.6); 3.977(3.8); 3.424(2.9); 3.409(6.7); 3.394(3.1); 3.306(50.0); 2.589(0.5); 2.570(1.6); 2.551(3.2); 2.532(5.5); 2.521(1.9); 2.513(5.3); 2.502(5.2); 2.495(2.0); 2.484(5.6); 2.465(3.1); 2.446(1.6); 2.427(0.5); 2.049(34.9); 2.036(0.4); 1.931(0.9); 1.921(1.6); 1.894(4.7); 1.863(3.3); 1.682(2.7); 1.651(4.7); 1.521(2.8); 1.509(4.8); 1.499(2.9); 1.197(0.7); 1.190(0.9); 1.177(20.5); 1.165(2.9); 1.158(44.3); 1.146(2.1); 1.139(20.3); 1.133(15.1); 1.124(1.3); 1.115(27.9); 1.106(1.1); 1.097(13.0); 1.083(0.4); 1.038(0.6); 0.901(1.1); 0.882(0.5); 0.008(0.4); 0.000(13.6); −0.009(0.4) Example Ia-5: ¹H-NMR( MHz, CDCl₃): δ = 7.266(0.4); 7.265(0.6); 7.262(45.3); 7.258(0.9); 7.256(0.5); 7.255(0.4); 7.126(13.8); 6.711(1.4); 5.299(2.1); 3.444(2.8); 3.429(6.6); 3.414(3.2); 3.326(50.0); 2.587(0.4); 2.568(1.4); 2.549(2.7); 2.534(1.6); 2.531(4.7); 2.517(4.3); 2.512(4.6); 2.500(7.0); 2.493(1.9); 2.482(4.3); 2.480(4.9); 2.465(1.5); 2.461(2.7); 2.447(0.3); 2.442(1.4); 2.424(0.5); 2.046(29.5); 1.919(1.6); 1.887(1.7); 1.838(0.9); 1.828(0.7); 1.804(2.3); 1.795(1.9); 1.771(1.6); 1.761(1.3); 1.691(2.5); 1.659(1.5); 1.594(16.1); 1.592(14.8); 1.554(0.6); 1.539(2.6); 1.524(3.9); 1.510(2.4); 1.498(0.9); 1.486(0.8); 1.460(0.4); 1.181(0.5); 1.169(17.2); 1.163(2.1); 1.150(38.2); 1.137(2.4); 1.131(17.5); 1.120(0.8); 1.110(1.1); 1.103(1.2); 1.077(0.5); 1.038(0.9); 1.025(0.4); 1.010(0.4); 0.999(0.6); 0.993(0.5); 0.978(45.5); 0.961(45.0); 0.901(0.5); 0.008(0.7); 0.000(24.5); −0.009(0.7) Example I-9: ¹H-NMR( MHz, d₆-DMSO): δ = 10.713(0.9); 7.069(0.5); 7.057(0.6); 3.339(0.4); 3.315(50.0); 3.251(4.2); 3.246(0.7); 2.510(6.2); 2.505(13.7); 2.500(19.3); 2.496(13.6); 2.491(6.2); 2.385(0.5); 2.367(0.5); 2.029(3.6); 1.025(0.5); 1.022(0.5); 1.007(1.0); 1.003(1.0); 0.988(0.5); 0.984(0.5) Example Ia-8: ¹H-NMR( MHz, CDCl₃): δ = 7.270(0.3); 7.2696(0.4); 7.269(0.4); 7.268(0.5); 7.267(0.7); 7.266(1.0); 7.263(50.0); 7.258(0.5); 7.127(4.7); 7.103(4.7); 6.999(0.3); 6.583(2.2); 4.131(0.5); 4.113(0.5); 4.037(2.6); 4.028(0.3); 4.019(8.7); 4.001(9.3); 3.983(3.1); 3.403(0.7); 3.401(1.0); 3.393(0.7); 3.385(0.7); 3.377(0.9); 3.370(2.3); 3.362(2.3); 3.354(2.7); 3.348(29.4); 3.342(30.6); 3.334(2.5); 3.328(2.9); 3.322(0.9); 3.311(0.7); 3.306(0.7); 2.548(0.5); 2.537(0.8); 2.529(1.0); 2.518(1.6); 2.511(1.8); 2.499(2.4); 2.492(2.1); 2.481(2.2); 2.475(2.2); 2.465(1.6); 2.456(1.8); 2.446(1.4); 2.438(0.9); 2.428(0.8); 2.419(0.5); 2.409(0.4); 2.303(0.5); 2.284(0.6); 2.279(0.7); 2.270(0.6); 2.260(0.7); 2.251(0.8); 2.245(1.0); 2.239(0.6); 2.227(0.9); 2.220(0.7); 2.211(0.8); 2.205(0.9); 2.191(12.4); 2.182(13.6); 2.054(0.9); 2.046(3.5); 2.041(35.7); 2.021(0.9); 2.013(1.3); 2.008(0.5); 2.001(1.4); 1.993(0.7); 1.980(1.3); 1.956(2.3); 1.933(3.4); 1.926(2.4); 1.917(1.2); 1.901(1.8); 1.893(0.5); 1.867(0.6); 1.862(0.9); 1.849(1.1); 1.829(1.5); 1.816(0.9); 1.796(0.6); 1.677(0.4); 1.663(0.7); 1.658(0.5); 1.652(0.5); 1.644(0.9); 1.639(0.8); 1.631(1.0); 1.625(0.8); 1.620(1.2); 1.608(13.3); 1.588(0.6); 1.278(0.7); 1.260(1.5); 1.242(0.7); 1.163(5.8); 1.157(5.3); 1.144(13.0); 1.139(11.5); 1.126(13.3); 1.120(5.4); 1.109(22.0); 1.091(10.3); 0.008(0.8); 0.000(27.5); −0.009(0.7) Example Ia-9: ¹H-NMR( MHz, CDCl₃): δ = 7.270(0.3); 7.269(0.4); 7.2684(0.4); 7.2676(0.5); 7.267(0.7); 7.266(1.0); 7.263(50.0); 7.259(1.5); 7.258(0.5); 7.257(0.3); 7.125(3.8); 7.101(3.8); 6.999(0.3); 6.920(1.3); 6.909(1.3); 4.131(0.5); 4.113(0.5); 4.035(1.7); 4.021(1.1); 4.017(5.5); 4.015(3.5); 4.003(1.2); 3.999(5.6); 3.985(0.5); 3.982(1.8); 3.461(0.8); 3.458(0.9); 3.453(0.9); 3.449(0.8); 3.438(1.4); 3.435(1.5); 3.430(1.5); 3.427(1.4); 3.410(23.2); 3.408(23.1); 3.381(2.1); 3.373(2.2); 3.355(3.8); 3.349(3.7); 2.555(0.7); 2.537(1.3); 2.518(2.3); 2.499(2.5); 2.479(1.9); 2.474(1.4); 2.460(1.2); 2.455(1.3); 2.449(1.2); 2.442(0.7); 2.436(0.8); 2.422(0.9); 2.416(1.4); 2.406(1.1); 2.388(0.7); 2.378(0.7); 2.372(1.1); 2.344(0.7); 2.218(0.3); 2.196(19.0); 2.182(1.3); 2.139(0.6); 2.118(0.9); 2.103(0.4); 2.094(0.8); 2.073(1.0); 2.058(0.7); 2.046(3.6); 2.039(29.0); 2.016(0.6); 2.008(1.0); 2.002(0.8); 1.987(0.4); 1.981(0.5); 1.963(0.3); 1.940(0.4); 1.877(1.0); 1.859(1.0); 1.847(1.9); 1.829(1.8); 1.812(0.7); 1.713(0.5); 1.706(0.9); 1.701(1.0); 1.679(0.6); 1.673(0.9); 1.666(0.9); 1.585(12.2); 1.321(0.6); 1.303(1.3); 1.290(1.5); 1.286(1.6); 1.278(2.4); 1.264(5.9); 1.260(6.0); 1.242(1.5); 1.174(0.3); 1.164(7.9); 1.158(1.0); 1.145(17.2); 1.139(2.0); 1.132(6.1); 1.130(6.7); 1.126(8.2); 1.120(1.2); 1.114(12.2); 1.112(12.7); 1.096(5.7); 1.094(5.8); 0.899(3.4); 0.882(12.6); 0.864(4.7); 0.008(0.8); 0.000(28.7); −0.008(0.8) Example I-10: ¹H-NMR( MHz, d₆-DMSO): δ = 10.693(0.5)7.068(0.5)7.057(0.5); 3.326(50.0); 3.295(0.4); 3.283(0.4); 3.278(0.4); 3.246(4.0); 2.510(4.1); 2.505(9.0); 2.501(12.7); 2.496(9.0); 2.491(4.1); 2.370(0.3); 2.035(1.3); 2.029(3.5); 1.024(0.4); 1.020(0.4); 1.005(1.0); 1.001(0.9); 0.986(0.4); 0.983(0.4) Example I-12: ¹H-NMR( MHz, d₆-DMSO): δ = 10.728(1.0); 8.135(1.3)7.736(0.9)7.411(1.5)7.046(6.0)7.029(6.0); 4.175(0.4); 4.157(1.1); 4.140(1.1); 4.122(0.4); 3.465(15.7); 3.422(0.7); 3.359(1.0); 3.342(1.4); 3.336(3.5); 3.320(4.2); 3.305(3.4); 3.293(0.7); 3.282(1.3); 3.263(0.9); 3.249(39.5); 3.244(7.7); 3.125(0.5); 2.835(0.5); 2.523(0.7); 2.510(16.7); 2.505(36.2); 2.501(50.0); 2.496(35.7); 2.492(16.2); 2.395(1.9); 2.375(11.0); 2.358(5.9); 2.339(2.6); 2.323(0.7); 2.224(1.0); 2.212(1.0); 2.201(0.9); 2.190(1.6); 2.178(1.2); 2.167(0.8); 2.155(0.8); 2.090(0.6); 2.074(0.5); 2.064(0.6); 2.054(0.7); 2.046(0.8); 2.023(21.6); 2.006(1.6); 1.995(0.7); 1.987(0.7); 1.978(0.6); 1.910(0.7); 1.897(0.9); 1.892(1.0); 1.880(1.1); 1.867(1.1); 1.862(1.1); 1.849(0.5); 1.801(0.3); 1.654(1.0); 1.637(1.1); 1.623(0.9); 1.588(0.8); 1.558(1.7); 1.545(2.3); 1.537(2.7); 1.533(1.8); 1.524(3.6); 1.516(1.7); 1.512(2.3); 1.504(2.1); 1.491(1.9); 1.470(1.1); 1.455(1.0); 1.437(0.9); 1.262(1.2); 1.245(2.4); 1.227(1.1); 1.059(0.4); 1.016(4.9); 1.013(5.1); 0.998(10.3); 0.994(10.5); 0.979(4.8); 0.975(4.7); 0.896(1.8); 0.885(4.7); 0.879(6.0); 0.870(2.7); 0.865(4.8); 0.858(5.5); 0.849(2.2); 0.833(0.3); 0.725(2.2); 0.716(6.0); 0.713(3.5); 0.710(5.3); 0.704(5.8); 0.697(5.5); 0.687(1.6); 0.008(0.4); 0.000(15.1); −0.009(0.5) Example Ia-12: ¹H-NMR( MHz, CDCl₃): δ = 7.263(50.0)7.112(6.7)7.090(6.5); 6.981(0.3); 6.518(2.7); 4.033(3.0); 4.015(9.5); 3.998(9.8); 3.980(3.2); 3.420(0.3); 3.400(5.5); 3.392(0.8); 3.383(0.8); 3.375(1.4); 3.368(2.9); 3.360(2.6); 3.347(25.6); 3.341(26.0); 3.333(2.8); 3.327(3.1); 3.321(0.9); 3.310(0.8); 3.304(0.7); 2.537(0.9); 2.526(1.1); 2.518(1.7); 2.508(2.1); 2.500(2.5); 2.489(3.0); 2.482(2.7); 2.470(2.8); 2.464(2.3); 2.454(2.1); 2.445(1.9); 2.436(1.8); 2.427(1.2); 2.417(1.0); 2.408(0.8); 2.398(0.7); 2.380(0.3); 2.299(0.5); 2.279(0.7); 2.275(0.7); 2.265(0.7); 2.256(0.9); 2.246(0.9); 2.240(1.2); 2.223(1.1); 2.215(0.9); 2.206(0.9); 2.201(0.9); 2.180(15.1); 2.170(14.7); 2.156(0.7); 2.111(0.3); 2.066(0.3); 2.050(0.7); 2.030(1.6); 2.017(1.0); 2.009(1.6); 1.997(1.8); 1.976(1.6); 1.951(2.7); 1.928(4.3); 1.921(2.8); 1.912(1.5); 1.896(2.0); 1.888(0.5); 1.857(1.2); 1.844(1.6); 1.823(2.0); 1.810(1.1); 1.790(0.8); 1.675(0.5); 1.661(0.9); 1.643(1.1); 1.638(0.9); 1.629(1.1); 1.618(1.2); 1.605(1.2); 1.591(7.3); 1.471(0.8); 1.458(1.7); 1.451(1.8); 1.446(1.1); 1.438(2.9); 1.425(1.9); 1.417(1.9); 1.405(1.0); 1.254(0.6); 1.156(6.3); 1.150(5.4); 1.137(14.3); 1.132(20.5); 1.115(24.6); 1.097(10.8); 0.881(1.7); 0.875(1.4); 0.868(3.6); 0.861(6.1); 0.854(3.7); 0.847(3.7); 0.841(6.0); 0.833(3.1); 0.827(1.5); 0.821(1.2); 0.809(3.1); 0.800(6.1); 0.795(5.9); 0.787(6.0); 0.782(5.1); 0.773(1.1); 0.769(1.3); 0.008(0.7); 0.000(25.7); −0.008(0.8) Example I-11: ¹H-NMR( MHz, d₆-DMSO): δ = 10.699(2.1)7.918(1.5)7.046(6.7); 7.029(7.0); 3.398(23.7); 3.336(0.8); 3.316(1.0); 3.305(0.8); 3.292(3.2); 3.280(4.1); 3.276(3.7); 3.263(3.9); 3.258(1.8); 3.248(9.0); 3.244(42.4); 2.533(0.4); 2.523(0.7); 2.509(16.9); 2.505(36.1); 2.501(50.0); 2.496(36.3); 2.492(17.2); 2.452(0.6); 2.397(1.4); 2.379(3.9); 2.361(4.1); 2.339(1.6); 2.327(0.5); 2.188(0.3); 2.146(0.4); 2.136(0.5); 2.122(0.7); 2.114(1.1); 2.103(1.1); 2.093(1.2); 2.084(1.0); 2.073(0.8); 2.061(0.8); 2.026(15.4); 2.022(16.9); 1.980(0.5); 1.960(1.1); 1.949(0.7); 1.940(1.2); 1.929(1.3); 1.909(1.2); 1.890(0.5); 1.831(1.0); 1.825(0.9); 1.799(2.1); 1.793(1.3); 1.773(1.3); 1.767(1.1); 1.653(1.0); 1.636(1.6); 1.620(1.5); 1.602(1.7); 1.588(1.3); 1.569(1.3); 1.558(1.7); 1.545(2.4); 1.537(2.3); 1.533(1.6); 1.524(3.7); 1.516(1.2); 1.512(2.1); 1.504(2.2); 1.491(1.4); 1.482(0.9); 1.476(0.9); 1.469(1.2); 1.457(1.2); 1.446(1.1); 1.438(0.8); 1.415(0.4); 1.016(5.6); 1.012(5.3); 0.997(11.8); 0.993(11.0); 0.978(5.5); 0.974(4.9); 0.896(2.0); 0.886(5.2); 0.879(6.6); 0.870(2.9); 0.865(5.2); 0.858(5.9); 0.849(2.3); 0.833(0.4); 0.813(0.3); 0.726(2.4); 0.717(6.5); 0.710(5.8); 0.704(6.2); 0.698(5.9); 0.687(1.8); 0.008(0.6); 0.000(19.1); −0.008(0.6) Example Ia-11: ¹H-NMR( MHz, CDCl₃): δ = 7.969(1.5); 7.283(2.0); 7.272(0.3); 7.271(0.4); 7.270(0.5); 7.269(0.7); 7.267(5.3)7.266; (4.9); 7.264; (48.0); 7.263; (50.0); 7.2585; (1.0); 7.2576; (0.7); 7.257(0.6); 7.256(0.4); 7.254(0.3); 7.111(8.0); 7.089(8.2); 6.920(2.7); 6.907(2.7); 6.231(0.7); 4.246(0.4); 4.229(1.3); 4.211(1.3); 4.193(0.5); 4.031(3.1); 4.014(9.8); 3.996(10.1); 3.978(3.4); 3.639(0.4); 3.454(1.5); 3.450(1.7); 3.432(2.8); 3.427(2.7); 3.407(43.9); 3.379(4.0); 3.370(4.2); 3.354(5.4); 3.353(5.4); 3.348(5.7); 3.142(0.7); 2.980(0.6); 2.565(0.4); 2.546(1.4); 2.527(2.8); 2.509(4.8); 2.490(5.2); 2.470(3.6); 2.464(2.6); 2.451(2.5); 2.445(4.0); 2.433(1.7); 2.423(8.3); 2.422(8.5); 2.411(2.6); 2.401(2.0); 2.383(1.3); 2.373(1.2); 2.367(1.9); 2.340(1.3); 2.232(0.4); 2.212(0.5); 2.185(34.6); 2.171(2.9); 2.134(1.2); 2.113(1.6); 2.097(0.7); 2.089(1.4); 2.068(1.9); 2.052(1.0); 2.027(2.1); 2.005(1.5); 1.999(1.5); 1.985(0.9); 1.979(0.9); 1.957(0.7); 1.934(0.8); 1.901(0.5); 1.891(0.5); 1.873(1.7); 1.855(1.9); 1.843(3.9); 1.825(3.6); 1.808(1.4); 1.696(2.0); 1.665(1.9); 1.586(15.8); 1.471(0.9); 1.458(1.9); 1.450(2.0); 1.445(1.2); 1.437(3.4); 1.425(2.2); 1.417(2.2); 1.404(1.2); 1.341(1.4); 1.323(2.7); 1.305(1.3); 1.259(0.3); 1.186(0.4); 1.158(11.7); 1.139(30.8); 1.119(33.8); 1.101(11.5); 1.083(0.4); 0.878(1.5); 0.872(1.4); 0.865(4.1); 0.859(7.3); 0.852(3.6); 0.844(4.6); 0.839(6.5); 0.830(3.2); 0.826(1.7); 0.818(1.3); 0.807(3.3); 0.799(8.3); 0.794(6.8); 0.787(7.5); 0.781(5.3); 0.771(1.4); 0.768(1.5); 0.008(0.7); 0.001(25.5); 0.000(27.0); −0.007(0.8) Example Ia-1: ¹H-NMR( MHz, CDCl₃): δ = 7.269(0.3); 7.2684(0.3); 7.2676(0.4); 7.267(0.6); 7.266(0.8); 7.262(50.0); 7.109(4.9); 7.087(4.8); 6.491(2.1); 4.025(2.8); 4.007(9.1); 3.989(9.2); 3.972(2.9); 3.381(0.6); 3.350(45.3); 3.332(9.5); 3.230(0.5); 3.214(0.5); 2.542(0.8); 2.523(1.4); 2.505(2.3); 2.485(2.7); 2.466(2.7); 2.446(2.5); 2.428(1.5); 2.409(0.8); 2.186(22.5); 2.159(0.4); 2.060(0.8); 2.039(1.5); 2.019(2.1); 1.999(1.1); 1.904(1.1); 1.781(0.8); 1.770(0.7); 1.757(1.7); 1.747(2.0); 1.736(2.1); 1.725(2.1); 1.719(1.9); 1.708(1.4); 1.692(1.0); 1.678(1.2); 1.660(3.4); 1.634(2.9); 1.616(1.2); 1.575(9.9); 1.470(0.7); 1.458(1.4); 1.450(1.5); 1.445(0.9); 1.437(2.4); 1.431(0.8); 1.424(1.5); 1.417(1.6); 1.404(0.9); 1.254(1.4); 1.187(0.3); 1.158(8.1); 1.139(17.2); 1.119(13.9); 1.101(19.6); 1.083(9.2); 0.881(1.5); 0.875(1.2); 0.868(2.9); 0.861(4.9); 0.854(2.8); 0.847(3.1); 0.841(4.8); 0.833(2.5); 0.827(1.2); 0.820(1.0); 0.808(2.6); 0.800(4.6); 0.795(4.5); 0.788(4.7); 0.782(4.1); 0.773(0.9); 0.769(1.1); 0.008(0.9); 0.004(0.3); 0.000(32.8); −0.005(0.8); −0.0056(0.6); −0.0065(0.5); −0.008(1.1) Example I-7: ¹H-NMR( MHz, CDCl₃): δ = 8.015(0.6); 7.520(0.3); 7.372(2.6); 7.261(50.0); 7.190(0.5); 7.110(5.1); 7.095(5.2); 7.033(0.3); 6.296(1.3); 3.887(0.9); 3.670(0.5); 3.623(0.4); 3.343(31.5); 3.331(7.2); 3.326(2.4); 3.309(0.3); 3.249(6.3); 3.233(6.6); 3.192(0.5); 3.115(0.4); 2.931(0.3); 2.883(19.6); 2.845(1.6); 2.790(17.4); 2.758(0.6); 2.649(0.4); 2.630(0.4); 2.493(0.4); 2.475(1.0); 2.463(1.1); 2.457(2.4); 2.445(2.7); 2.438(2.6); 2.426(2.8); 2.419(1.1); 2.408(1.2); 2.397(0.3); 2.390(0.4); 2.301(0.4); 2.288(0.9); 2.226(0.4); 2.167(0.6); 2.157(0.4); 2.129(0.4); 2.107(21.4); 2.035(0.5); 1.982(1.4); 1.966(1.4); 1.938(2.6); 1.923(2.3); 1.896(2.0); 1.773(0.5); 1.735(0.8); 1.724(0.7); 1.652(0.8); 1.644(1.0); 1.636(0.9); 1.614(2.7); 1.587(1.9); 1.468(0.8); 1.455(1.6); 1.449(3.1); 1.443(1.2); 1.435(2.9); 1.428(1.1); 1.422(1.8); 1.414(1.8); 1.402(0.9); 1.255(0.9); 1.237(0.3); 1.225(0.4); 1.210(0.5); 1.193(1.1); 1.182(2.3); 1.174(1.2); 1.153(2.0); 1.122(1.7); 1.109(1.0); 1.098(8.4); 1.090(1.8); 1.079(17.4); 1.060(7.8); 0.887(1.3); 0.874(3.1); 0.868(4.9); 0.859(3.4); 0.854(3.4); 0.847(4.2); 0.839(2.5); 0.821(1.0); 0.805(1.1); 0.800(2.4); 0.791(4.7); 0.786(4.5); 0.779(4.9); 0.773(4.5); 0.768(1.7); 0.760(1.2); 0.008(0.7); 0.000(29.2); −0.008(1.0) Example Ia-6: ¹H-NMR( MHz, CDCl₃): δ = 7.261(50.0); 7.104(7.2); 7.086(7.4); 6.630(2.5); 3.398(1.2); 3.395(1.3); 3.373(0.8); 3.357(1.1); 3.350(3.2); 3.340(37.2); 3.330(38.8); 3.321(4.1); 3.315(5.2); 3.298(0.9); 3.291(0.4); 2.561(1.6); 2.548(0.9); 2.543(4.2); 2.537(1.3); 2.526(6.1); 2.518(2.3); 2.508(5.7); 2.500(3.2); 2.491(4.5); 2.481(3.1); 2.471(2.8); 2.460(2.6); 2.452(2.4); 2.441(2.2); 2.433(1.4); 2.423(1.3); 2.415(0.8); 2.404(0.7); 2.227(0.7); 2.207(1.1); 2.204(1.1); 2.187(20.0); 2.179(19.1); 2.151(1.8); 2.142(0.8); 2.132(1.0); 2.122(1.2); 2.099(1.1); 2.036(48.2); 2.020(1.9); 2.001(1.5); 1.987(1.9); 1.967(1.7); 1.947(1.3); 1.930(2.4); 1.920(3.6); 1.914(2.5); 1.896(3.5); 1.887(0.7); 1.864(2.5); 1.847(1.1); 1.839(2.8); 1.830(2.4); 1.820(1.3); 1.815(1.6); 1.805(1.7); 1.797(1.1); 1.782(0.7); 1.651(0.5); 1.638(0.5); 1.628(1.1); 1.615(1.1); 1.610(1.1); 1.605(1.1); 1.590(5.4); 1.577(1.1); 1.564(0.8); 1.554(0.5); 1.541(0.4); 1.258(0.8); 1.244(0.3); 1.154(7.0); 1.148(7.2); 1.135(15.4); 1.129(15.5); 1.116(6.9); 1.110(6.8); 1.012(17.4); 1.010(19.4); 0.995(17.9); 0.992(19.8); 0.987(16.8); 0.982(16.6); 0.970(15.6); 0.964(16.4); 0.948(0.8); 0.008(0.8); 0.000(33.3); −0.002(12.6); −0.008(0.9) Example Ia-16: ¹H-NMR( MHz, CDCl₃): δ = 7.267(0.3); 7.2666(0.5); 7.262(37.0); 7.256(0.4); 7.212(2.5); 7.174(7.3); 7.149(7.2); 7.068(0.7); 7.016(0.4); 4.054(0.4); 4.037(0.7); 4.021(0.4); 3.615(0.6); 3.388(2.7); 3.370(2.8); 3.352(14.9); 3.327(1.9); 3.315(50.0); 3.220(9.3); 3.205(9.5); 2.859(1.1); 2.777(0.6); 2.598(0.3); 2.579(1.0); 2.561(2.1); 2.542(3.7); 2.530(1.3); 2.523(3.6); 2.511(3.6); 2.504(1.4); 2.493(3.8); 2.474(2.2); 2.462(0.4); 2.455(1.3); 2.440(43.2); 2.422(12.1); 2.378(0.3); 2.323(0.3); 2.263(0.3); 2.241(0.6); 2.222(34.1); 2.115(0.4); 2.101(0.5); 2.088(0.7); 2.063(2.3); 2.044(48.1); 2.022(1.2); 2.009(1.3); 1.999(1.9); 1.976(2.7); 1.965(5.5); 1.951(2.9); 1.940(4.0); 1.929(3.1); 1.915(3.0); 1.878(0.6); 1.867(0.5); 1.830(0.6); 1.818(0.6); 1.748(0.6); 1.737(0.8); 1.706(2.3); 1.700(2.3); 1.690(2.0); 1.673(3.6); 1.652(1.8); 1.644(2.1); 1.622(2.1); 1.588(0.7); 1.570(0.6); 1.555(0.5); 1.448(0.3); 1.430(0.3); 1.252(1.0); 1.240(0.9); 1.207(2.2); 1.191(13.5); 1.172(29.8); 1.153(12.9); 1.089(0.4); 1.076(0.4); 1.070(1.0); 1.051(1.0); 1.032(0.4); 0.983(0.8); 0.965(1.5); 0.946(0.6); 0.008(0.6); 0.000(22.0); −0.008(0.6) Example Ia-10: ¹H-NMR( MHz, CDCl₃): δ = 7.262(50.0); 7.205(1.0); 7.070(18.7); 6.916(3.0); 6.371(1.5); 4.055(0.6); 4.051(0.7); 4.037(0.6); 4.033(0.9); 4.029(2.2); 4.026(3.5); 4.011(6.9); 4.008(10.9); 3.994(7.0); 3.990(11.0); 3.976(2.3); 3.972(3.6); 3.450(1.7); 3.442(1.8); 3.428(3.3); 3.419(3.1); 3.406(4.0); 3.402(43.0); 3.389(1.0); 3.378(3.4); 3.370(3.8); 3.367(3.0); 3.356(2.5); 3.345(28.5); 3.333(2.5); 3.327(0.9); 3.310(0.8); 2.529(0.6); 2.511(1.4); 2.501(1.1); 2.491(1.6); 2.485(1.1); 2.472(1.3); 2.455(0.4); 2.423(2.7); 2.395(1.7); 2.389(2.9); 2.362(1.8); 2.285(0.6); 2.266(0.8); 2.261(0.8); 2.252(0.7); 2.242(0.8); 2.233(1.1); 2.228(0.9); 2.209(0.9); 2.193(3.2); 2.184(1.7); 2.170(28.2); 2.166(41.9); 2.157(16.1); 2.129(0.5); 2.112(1.9); 2.091(2.5); 2.070(0.6); 2.051(1.8); 2.029(1.8); 2.018(1.4); 2.009(1.7); 2.001(2.0); 1.990(0.6); 1.979(1.3); 1.957(0.5); 1.939(4.2); 1.917(3.7); 1.883(0.6); 1.866(1.5); 1.855(1.4); 1.842(3.2); 1.836(2.8); 1.830(1.5); 1.821(3.8); 1.801(1.5); 1.789(0.5); 1.702(1.3); 1.698(1.4); 1.694(1.4); 1.676(0.6); 1.669(1.3); 1.664(1.6); 1.644(0.7); 1.634(0.6); 1.625(0.5); 1.620(0.7); 1.611(0.5); 1.606(0.4); 1.601(0.5); 1.587(10.7); 1.460(1.0); 1.447(2.0); 1.439(2.1); 1.434(1.3); 1.426(3.7); 1.420(1.2); 1.414(2.2); 1.406(2.4); 1.393(1.2); 1.264(0.8); 1.154(0.8); 1.134(12.9); 1.116(24.5); 1.114(16.6); 1.098(11.4); 1.096(8.0); 0.899(0.4); 0.882(1.4); 0.874(1.0); 0.871(1.5); 0.862(2.4); 0.853(5.5); 0.847(2.6); 0.844(3.5); 0.841(2.4); 0.837(4.0); 0.834(4.0); 0.831(5.0); 0.827(2.1); 0.823(2.7); 0.813(1.5); 0.810(1.0); 0.794(3.6); 0.786(6.2); 0.781(5.7); 0.774(7.1); 0.768(5.2); 0.760(1.2); 0.755(1.3); 0.008(0.7); 0.000(29.1); −0.008(0.9) Example I-14: ¹H-NMR( MHz, d₆-DMSO): δ = 10.713(0.6); 7.898(0.3); 7.713(0.6); 7.267(0.6); 7.249(2.4); 7.230(1.7); 7.181(1.8); 7.163(1.5); 7.142(0.8); 7.029(12.1); 3.423(8.7); 3.361(0.6); 3.338(2.1); 3.324(2.4); 3.321(2.3); 3.307(2.1); 3.293(1.4); 3.282(1.5); 3.276(1.3); 3.265(1.3); 3.250(25.1); 3.245(15.9); 2.544(0.3); 2.509(15.6); 2.504(35.2); 2.499(50.0); 2.495(35.5); 2.490(16.0); 2.377(0.5); 2.358(0.7); 2.335(0.6); 2.299(7.3); 2.226(1.0); 2.202(0.9); 2.192(1.4); 2.168(0.9); 2.123(0.5); 2.095(0.6); 2.071(2.4); 2.037(28.1); 2.016(1.1); 2.005(0.7); 1.988(0.8); 1.963(0.4); 1.911(0.7); 1.882(0.7); 1.833(0.6); 1.801(0.8); 1.775(0.6); 1.651(1.0); 1.635(0.7); 1.619(0.9); 1.593(0.5); 1.564(0.8); 1.552(1.1); 1.539(2.0); 1.531(1.6); 1.527(1.0); 1.519(3.1); 1.511(1.1); 1.506(1.7); 1.498(1.8); 1.486(1.3); 1.472(1.1); 1.457(0.9); 1.439(0.8); 0.895(1.4); 0.884(3.7); 0.878(4.9); 0.868(2.0); 0.864(3.8); 0.857(4.3); 0.848(1.7); 0.718(1.7); 0.709(4.8); 0.702(4.2); 0.697(4.6); 0.690(4.3); 0.680(1.2); 0.008(0.7); 0.000(27.3); −0.009(0.8) Example I-8: ¹H-NMR( MHz, d₆-DMSO): δ = 10.635(5.0); 10.594(1.4); 8.044(2.8); 7.948(0.7); 7.268(0.7); 7.249(2.0); 7.230(1.8); 7.181(2.0); 7.163(1.6); 7.142(0.9); 7.124(0.3); 7.026(13.8); 6.979(0.3); 3.362(1.3); 3.343(1.6); 3.320(49.2); 3.259(8.3); 3.235(28.7); 3.165(4.9); 3.149(5.1); 2.509(16.1); 2.504(35.7); 2.500(50.0); 2.495(35.5); 2.490(16.1); 2.299(7.7); 2.280(0.6); 2.210(0.7); 2.076(2.5); 2.044(42.1); 1.898(1.3); 1.874(2.0); 1.840(1.2); 1.716(1.5); 1.686(1.7); 1.551(1.4); 1.539(2.0); 1.530(2.1); 1.526(1.5); 1.518(3.4); 1.506(1.9); 1.498(1.8); 1.485(1.0); 1.396(2.0); 1.358(2.3); 1.324(1.8); 1.294(1.6); 1.261(0.5); 0.894(1.6); 0.883(4.0); 0.877(5.2); 0.868(2.4); 0.863(4.2); 0.856(4.6); 0.847(1.9); 0.718(1.9); 0.709(5.2); 0.703(4.6); 0.697(5.0); 0.690(4.7); 0.680(1.5); 0.008(0.5); 0.000(14.6); −0.009(0.4) Example Ia-2: ¹H-NMR( MHz, CDCl₃): δ = 7.261(37.4); 7.206(0.8); 7.070(14.2); 6.859(2.2); 4.131(0.6); 4.113(0.6); 4.050(0.6); 4.032(0.7); 4.024(3.2); 4.007(9.8); 3.989(10.0); 3.971(3.2); 3.693(0.6); 3.350(2.3); 3.333(38.7); 3.303(0.4); 3.300(0.4); 3.232(8.1); 3.217(8.2); 2.358(0.3); 2.324(0.3); 2.298(0.4); 2.195(3.2); 2.167(50.0); 2.044(2.9); 2.005(0.4); 1.948(2.1); 1.926(3.3); 1.913(2.6); 1.901(4.1); 1.890(2.1); 1.867(2.0); 1.857(1.5); 1.704(3.4); 1.667(2.8); 1.650(1.0); 1.642(0.9); 1.628(0.7); 1.587(10.7); 1.460(0.7); 1.447(1.4); 1.439(1.5); 1.435(0.9); 1.426(2.6); 1.420(0.8); 1.414(1.5); 1.406(1.6); 1.393(0.9); 1.277(1.1); 1.259(2.0); 1.241(1.3); 1.237(1.0); 1.204(2.3); 1.195(1.7); 1.173(2.0); 1.165(1.6); 1.152(0.9); 1.132(10.7); 1.114(21.5); 1.101(1.7); 1.096(9.9); 1.084(0.6); 0.899(0.5); 0.882(1.5); 0.874(1.5); 0.867(1.6); 0.861(3.3); 0.855(5.1); 0.847(3.4); 0.841(3.2); 0.834(4.1); 0.826(2.5); 0.814(1.1); 0.794(3.2); 0.786(5.0); 0.781(4.6); 0.774(5.4); 0.768(4.5); 0.761(1.1); 0.755(1.2); 0.008(0.7); 0.0004(19.8); −0.0002(22.6); −0.009(0.7) Example I-13: ¹H-NMR( MHz, d₆-DMSO): δ = 10.689(0.9); 7.897(0.6); 7.030(3.7); 3.326(50.0); 3.293(0.8); 3.282(0.8); 3.276(1.0); 3.265(0.8); 3.250(2.5); 3.245(9.6); 2.509(12.0); 2.505(26.9); 2.500(38.0); 2.496(26.8); 2.491(12.0); 2.072(0.6); 2.041(5.9); 2.036(6.6); 1.831(0.3); 1.799(0.5); 1.774(0.4); 1.651(0.3); 1.635(0.3); 1.601(0.3); 1.540(0.5); 1.532(0.4); 1.519(0.9); 1.507(0.5); 1.499(0.5); 1.486(0.4); 0.895(0.4); 0.885(1.1); 0.878(1.5); 0.869(0.6); 0.864(1.2); 0.858(1.3); 0.848(0.5); 0.719(0.6); 0.709(1.5); 0.703(1.3); 0.697(1.4); 0.690(1.3); 0.680(0.4); 0.000(5.2)

C. Formulation Examples

a) A dusting product is obtained by mixing 10 parts by weight of a compound of the formula (I) and/or salts thereof and 90 parts by weight of talc as inert substance and comminuting the mixture in an impact mill. b) A readily water-dispersible, wettable powder is obtained by mixing 25 parts by weight of a compound of the formula (I) and/or salts thereof, 64 parts by weight of kaolin-containing quartz as inert substance, 10 parts by weight of potassium ligninosulphonate and 1 part by weight of sodium oleoylmethyltaurate as wetting agent and dispersant and grinding in a pinned-disc mill. c) A readily water-dispersible dispersion concentrate is obtained by mixing 20 parts by weight of a compound of the formula (I) and/or salts thereof with 6 parts by weight of alkylphenol polyglycol ether (® Triton X 207), 3 parts by weight of isotridecanol polyglycol ether (8 EO) and 71 parts by weight of paraffinic mineral oil (boiling range e.g. about 255 to more than 277° C.) and grinding to a fineness of below 5 microns in an attrition ball mill. d) An emulsifiable concentrate is obtained from 15 parts by weight of a compound of the formula (I) and/or salts thereof, 75 parts by weight of cyclohexanone as solvent and 10 parts by weight of oxethylated nonylphenol as emulsifier. e) Water-dispersible granules are obtained by mixing 75 parts by weight of a compound of the formula (I) and/or salts thereof, 10 parts by weight of calcium ligninosulphonate, 5 parts by weight of sodium laurylsulphate, 3 parts by weight of polyvinyl alcohol and 7 parts by weight of kaolin, grinding the mixture in a pinned-disc mill, and granulating the powder in a fluidized bed by spray application of water as a granulating liquid. f) Water-dispersible granules are also obtained by homogenizing and precomminuting 25 parts by weight of a compound of the formula (I) and/or salts thereof, 5 parts by weight of sodium 2,2′ dinaphthylmethane-6,6′ disulphonate, 2 parts by weight of sodium oleoylmethyltaurate, 1 part by weight of polyvinyl alcohol, 17 parts by weight of calcium carbonate and 50 parts by weight of water on a colloid mill, then grinding the mixture in a bead mill and atomizing and drying the resulting suspension in a spray tower by means of a one-phase nozzle.

D. Biological Data 1. Pre-Emergence Herbicidal Effect and Crop Plant Compatibility

Seeds of monocotyledonous and dicotyledonous weed plants and crop plants are laid out in wood-fibre pots in sandy loam and covered with soil. The compounds according to the invention formulated in the form of wettable powders (WP) or as emulsion concentrates (EC) are then applied as aqueous suspension or emulsion at a water application rate of 600 to 800 I/ha (converted) with the addition of 0.2% wetting agent to the surface of the covering soil.

After the treatment, the pots are placed in a greenhouse and kept under good growth conditions for the trial plants. The damage to the test plants is scored visually after a test period of 3 weeks by comparison with untreated controls (herbicidal activity in percent (%): 100% activity=the plants have died, 0% activity=like control plants).

Undesired Plants/Weeds:

ALOMY: Alopecurus SETVI: Setaria viridis myosuroides AMARE: Amaranthus AVEFA: Avena fatua retroflexus CYPES: Cyperus esculentus ECHCG: Echinochloa crus-galli LOLMU: Lolium multiflorum STEME: Stellaria media VERPE: Veronica persica VIOTR: Viola tricolor POLCO: Polygonum convolvulus

TABLE 5 Pre-emergence effectiveness Dosage Ex. No. [g/ha] ALOMY AVEFA CYPES ECHCG LOLMU SETVI AMARE VIOTR VERPE I-1 320 100 80 100 100 100 80 80 100 100 100 I-2 320 100 100 100 100 100 100 100 80 100 80 100 100 100 I-5 320 100 100 100 100 100 100 80 80 100 100 100 100 100 I-7 320 100 100 100 100 80 80 100 100 90 I-8 320 100 100 100 90 90 80 90 100 90 80 I-9 320 100 90 100 100 100 80 100 100 80 90 I-10 320 100 100 100 100 100 80 90 80 100 100 80 I-11 320 100 80 100 100 100 100 80 80 100 100 100 90 I-12 320 100 80 100 100 100 80 100 90 100 90 I-13 320 100 100 90 100 80 100 90 I-14 320 100 80 100 100 90 80 100 90

TABLE 6 Pre-emergence effectiveness Dosage Ex. No. [g/ha] ALOMY AVEFA CYPES ECHCG LOLMU SETVI AMARE VIOTR VERPE Ia-1 320 100 90 100 100 100 90 80 90 80 100 100 100 Ia-2 320 100 100 100 80 100 80 80 100 90 Ia-3 320 100 90 100 100 100 90 80 90 80 100 100 100 Ia-4 320 80 100 90 100 100 90 80 100 100 Ia-5 320 100 100 100 100 100 100 100 100 80 100 80 100 100 100 100 Ia-6 320 100 90 100 100 100 80 100 90 100 100 100 Ia-7 80 100 100 100 100 Ia-8 320 100 90 100 100 100 80 100 90 100 100 80 Ia-10 320 100 80 100 100 100 80 90 100 80 90 Ia-11 320 100 80 100 100 100 80 100 100 100 100 Ia-12 320 100 90 100 100 100 80 100 100 100 90 Ia-13 320 100 100 100 100 100 80 100 80 100 100 100 Ia-14 320 100 80 100 100 100 100 80 80 80 100 90 100 Ia-16 320 90 100 90 90 80 90 90 90

As the results from Tables 5 and 6 show, compounds according to the invention have a good herbicidal pre-emergence effectiveness against a broad spectrum of weed grasses and weeds. For example, the compounds No. I-1, I-2, I-5, I-9, I-10, I-11, I-12, I-14, Ia-1, Ia-2, Ia-3, Ia-5, Ia-6, Ia-8, Ia-9, Ia-10, Ia-11, Ia-12, Ia-13 and Ia-14, and at an application rate of 320 g/ha in each case exhibit an 80-100% effect against Alopecurus myosuroides, Avena fatua, Echinochloa crus-galli, Lolium multiflorum and Setaria viridis. The compounds I-7, I-8, I-13, Ia-4 and Ia-16, by contrast, at an application rate of 320 g/ha in each case exhibit an 80-100% effect against Alopecurus myosuroides, Echinochloa crus-galli, Lolium multiflorum and Setaria viridis. Accordingly, the compounds according to the invention are suitable for controlling unwanted plant growth by the pre-emergence method.

2. Post-Emergence Herbicidal Effect and Crop Plant Compatibility

Seeds of monocotyledonous and dicotyledonous weed and crop plants are laid out in sandy loam in wood-fibre pots, covered with soil and cultivated in a greenhouse under good growth conditions. 2 to 3 weeks after sowing, the test plants are treated at the one-leaf stage. The compounds according to the invention, formulated in the form of wettable powders (WP) or as emulsion concentrates (EC), are then sprayed as aqueous suspension or emulsion at a water application rate of 600 to 800 I/ha (converted) with the addition of 0.2% of wetting agent onto the green parts of the plants. After the test plants have been left to stand in the greenhouse under optimal growth conditions for about 3 weeks, the action of the preparations is assessed visually in comparison to untreated controls (herbicidal action in percent (%): 100% activity=the plants have died, 0% activity=like control plants).

TABLE 7 Post-emergence effectiveness Dosage Ex. No. [g/ha] ALOMY AVEFA ECHCG LOLMU SETVI POLCO VERPE I-1 80 90 90 100 90 100 20 100 90 90 I-2 80 100 100 100 100 100 20 90 90 100 90 100 I-5 80 100 100 100 100 100 20 90 90 100 90 90 I-7 80 100 100 100 100 100 80 20 90 100 90 100 I-8 80 100 80 100 90 100 20 90 100 90 100 I-9 80 100 100 100 100 100 20 100 90 100 100 100 I-10 80 100 100 100 100 100 20 100 100 100 100 90 I-11 80 100 100 100 100 100 20 80 80 100 90 100 I-12 80 90 80 100 90 100 20 80 100 100 I-13 80 80 90 90 90 20 90 90 I-14 80 80 100 90 90 20 90 90 90

TABLE 8 Post-emergence action Dosage Ex. No. [g/ha] ALOMY AVEFA ECHCG LOLMU SETVI POLCO VERPE Ia-1 80 80 100 90 20 90 Ia-2 80 80 80 Ia-3 80 100 100 100 100 90 20 90 90 90 Ia-6 80 100 100 90 100 20 100 90 Ia-7 80 100 100 100 80 20 90 Ia-8 80 100 100 100 100 100 20 100 100 100 100 Ia-9 80 100 90 100 90 100 20 100 90 100 90 100 Ia-10 80 80 90 90 100 20 90 80 100 Ia-11 80 90 100 90 90 20 100 80 Ia-12 80 90 100 100 100 100 20 90 100 100 90 100 Ia-13 80 100 80 20 80

As the results from Tables 7 and 8 show, compounds according to the invention have a good herbicidal post-emergence effectiveness against a broad spectrum of weed grasses and weeds. For example, the compounds No. I-1, I-2, I-5, I-7, I-8, I-9, I-10, I-11, I-12, I-13, I-14, Ia-3, Ia-6, Ia-7, Ia-8, Ia-9, Ia-11 and Ia-12, and at an application rate of 80 g/ha in each case exhibit an 80-100% effect against Alopecurus myosuroides, Avena fatua, Echinochloa crus-galli, Lolium multiflorum and Setaria viridis.

Accordingly, the compounds according to the invention are suitable for controlling unwanted plant growth by the post-emergence method.

Compared to the closest prior art (WO 2015/040114, compound 42.03), the compounds of the present invention have an improved herbicidal effect both pre-emergence and post-emergence, as the following table shows.

TABLE 9 Comparison data for pre-emergence effectiveness Dosage Ex. No. (g a. i. /ha) AVEFA CYPES SETVI Ia-17 20 60 100 100

20 50 0 80 WO 2015/040114

TABLE 10 Comparison data for post-emergence effect Dosage Ex. No. (g a. i. /ha) ALOMY AVEFA PHBPU I-5 20 90 90 30

20 80 70 0 WO 2015/040114 

1. An alkynyl-substituted phenyl acetic acid of formula (VII),

wherein X is C₁-C₄-alkyl, C₁-C₄-haloalkyl or C₃-C₆-cycloalkyl; Y is C₁-C₄-alkyl or C₃-C₆-cycloalkyl; and R¹ is C₁-C₆-alkyl or C₃-C₆-cycloalkyl; with the proviso that the compound 2,6-dimethyl-4-propargylphenyl acetic acid is excluded.
 2. The alkynyl-substituted phenyl acetic acid of formula (VII) according to claim 1, wherein X is methyl, ethyl or cyclopropyl; Y is methyl or ethyl; and R¹ is methyl, ethyl, isopropyl or cyclopropyl.
 3. The alkynyl-substituted phenyl acetic acid of formula (VII) according to claim 2, wherein X is methyl or ethyl.
 4. The alkynyl-substituted phenyl acetic acid of formula (VII) according to claim 1, wherein X is ethyl; Y is ethyl; and R¹ is methyl.
 5. The alkynyl-substituted phenyl acetic acid of formula (VII) according to claim 1, wherein X is methyl; Y is methyl; and R¹ is methyl.
 6. The alkynyl-substituted phenyl acetic acid of formula (VII) according to claim 1, wherein X is methyl; Y is ethyl; and R¹ is cyclopropyl.
 7. The alkynyl-substituted phenyl acetic acid of formula (VII) according to claim 1, wherein X is methyl; Y is methyl; and R¹ is cyclopropyl. 